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The thymus is the primary lymphoid organ where immature thymocytes 
differentiate and mature to become functional T cells that are self-MHC restricted and self-
tolerant. In addition to developing T cells, the thymus is comprised of stromal cells, 
subdivided into cortical and medullary regions, which form a component of the 
microenvironment for thymocyte development. Throughout their development, 
thymocytes undergo bidirectional crosstalk with the thymic epithelial cells, which is 
essential for proper development of both the thymocyte and epithelial subsets.  
Thymic involution is a detrimental process of aging which results in degeneration 
of the thymic microenvironment, reduction in T cell output, and contraction of the naïve T 
cell pool, thus contributing to impaired immune responses in aging individuals. Molecular 
and cellular changes that drive thymic atrophy during aging are not well understood. To 
address this gap in knowledge, I analyzed transcriptional changes in purified thymic 
stromal subsets early in the process of age-associated thymic involution (Chapter 2). These 
 vii 
studies revealed that there is gradual down-regulation of cell cycle genes and E2F3 
transcriptional targets in thymic epithelial cell subsets as the thymus begins to involute. 
This suggests that diminished proliferative activity in a subset of thymic epithelial cells is 
a major contributing factor to age-associated involution. I also identified an increasingly 
proinflmamatory signature in thymic dendritic cells early in the involution process. These 
results have provided novel insights into the mechanisms behind thymic atrophy and 
identify cellular targets for thymic rebound strategies.  
Chemokine receptors, a subset of G protein coupled receptors (GPCRs), have been 
implicated in guiding thymocytes between different thymic regions, thus enabling 
interactions with local stromal subsets that support T cell differentiation. For example, 
chemokine receptors play an essential role in driving thymocyte migration into the medulla, 
where thymocytes scan numerous self-antigens to establish central tolerance. Importantly, 
failure of thymocytes to enter the thymic medulla results in impaired self-tolerance, leading 
to autoimmunity. We have identified EBI2 and GPR146 as candidate GPCRs that could 
contribute to thymocyte accumulation in the medulla, interactions with antigen presenting 
cells therein, and thus the induction of tolerance. In chapter 3, I report that EBI2 is essential 
for negative selection toward some self-antigens and restrains regulatory T cell generation 
in the thymus. Through two-photon imaging, I identified reduced motility and medullary 
accumulation as mechanisms by which EBI2 deficiency could impair negative selection. 
In chapter 4, I describe generation of a GPR146 deficient mouse strain, and initial studies 
indicating GPR146 is involved in thymocyte differentiation and selection. Through these 
studies we have revealed novel functions for GPCRs in promoting thymocyte migration 
and the induction of self-tolerance. 
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Chapter 1:  Introduction 
 
1.1 THYMOCYTE DEVELOPMENT 
A healthy immune system must be able to protect hosts from infection and 
malignant outgrowth by initiating a powerful immune response. However, this same 
powerful system also has the capability to cause collateral damage to healthy, non-infected 
tissue when eliminating pathogens, or in extreme cases, develop immune responses 
activated by self-tissue in the absence of infections (autoimmunity). Thus the immune 
system requires multiple layers of control mechanisms to keep the immune system well-
balanced. Besides having innate immune system in our body, adaptive immune system is 
important for having pathogen specificity and immunological memory. One of the major 
lymphocyte subsets in the adaptive immune system are T cells, which are so named because 
they differentiate in the thymus from immature precursors called thymocytes. The thymus 
is a primary lymphoid organ that provides a specialized environment for differentiation of 
T cells from hematopoietic progenitors. The thymus consists of not only developing T cells, 
or thymocytes, but also of heterogeneous thymic stormal cells. The thymus is broadly 
organized into two main areas, the outer cortex and inner medulla. Both compartments 
contain unique stromal subsets such as medullary thymic epithelial cells (mTECs), cortical 
thymic epithelial cells (cTECs), and dendritic cells (DCs) that provide essential signals 
required for proper T cell development (1).  
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Early thymocyte progenitors, derived from precursors in the bone marrow, enter 
the thymus through blood vessels at the cortico-medullary junction (CMJ) (2). T cells 
differentiate through several discrete stages as they mature. Double negative cells (DNs), 
so named because they do not express either CD4 and CD8 on their surface, are the earliest 
thymocyte progenitors. When hematopoietic progenitors enter the thymus at the CMJ, they 
are not yet committed to the T cell lineage. Through interactions with stromal cells in the 
cortex, DN cells commit to the T cell lineage (3). Once they committed to the T cell lineage, 
T cells go through multiple steps to express unique and functional T cell receptors (TCR) 
on their surface. The TCR is essential for recognizing foreign antigen presented by host-
antigen presenting cells. When an infection has occurred, short forms of the peptides that 
are derived from the pathogen proteome is presented on self-MHC molecules on antigen 
presenting cells. Unique TCRs expressed on thymocytes must be able to recognize peptide-
self-MHCII complexes. Since rearrangement is mostly random, it is important that 
thymocytes express a wide range of TCRs by gene rearrangement and form polyclonal 
TCR repertoire during the developmental process to have the potential to recognize an 
array of potential foreign antigens presented by self-MHC (4, 5). 
More mature DN cells then migrate towards the middle of the cortex where they 
begin to rearrange their T cell receptor beta chain (TCRβ) genes, through a process known 
as VDJ recombination (6). Those cells that do not make an in-frame TCRβ rearrangement 
fail to express TCRβ protein, and they undergo apoptosis. The process which check 
successful generation of TCRβ chain is called β-selection. If a functional TCRβ chain is 
produced, it is pared with pre-TCR-α chain, which is a fixed, non-rearranged generated 
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alpha gene, to form a complex called the pre-TCR. They signal through the pre-TCR, 
survive, proliferate, and differentiate into double positive (DP) thymocytes that express 
both CD4 and CD8 co-receptors. DP cells are localized throughout the cortex, where they 
undergo TCRα chain gene rearrangements, giving them the opportunity to express a 
functional TCRαβ heterodimer on their surface. DP cells that successfully express TCRαβ 
are subject to positive selection, which ensures survival of only those thymocytes that 
express TCRs that are self-major histocompatibility complex (MHC)-restricted. Positive 
selection ensures that only thymocytes with potentially functional TCRs mature 
(Figure1.1) (6-9). 
Positive selection occurs in the cortex where cTECs present self-peptide:MHC 
complexes on their surfaces (Figure1.1). Low avidity interactions between the TCRs on 
DP thymocytes and self-peptide:MHC complexes on cTECs lead to survival of DP cells 
and up-regulation of chemokine receptors (such as CCR4(10)), enabling post-positive 
selection cells to migrate toward the medulla, where they undergo further maturation. If a 
DP cell undergoes positive selection following a TCR interaction with peptide presented 
on MHC-I it differentiates into a CD8+ single positive (SP) cell, while positive selection in 
response to MHC-II complexes drives differentiation into the CD4+ SP lineage. CD4+ T 
cells are helper T cells which promote immune response by secreting cytokines. CD8+ T 
cells are called cytotoxic T cells, which abolish pathogen-infected cells. 
Once SP cells enter the medulla, they are subject to negative selection, the process 
by which cells bearing TCRs with high affinity for self-antigens are eliminated, thus 
preventing export of autoreactive T cells that induce autoimmunity. SP cells scan self-
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peptide:MHC complexes presented by mTECs and DCs in the medulla. Recently, several 
studies have shown that negative selection occurs not only in medulla, but also in cortex. 
(11-13) Using Bim-/-; Nur77GFP mice in which TCR signaling can be monitored by GFP 
level and negatively selected thymocytes are rescued by blocking apoptosis, it is shown 
that there are DP thymocytes undergoing negative selection in cortex. (12, 13) This 
suggests that antigen presenting cells in cortex may contribute to eliminating autoreactive 
thymocytes.    
 SP cells that interact with self-peptide:MHCs with intermediate affinity are more 
likely to differentiate into regulatory T cells (Tregs), whose role in the periphery is to 
actively suppress immune responses against self-antigens (7, 8). There are several 
mechanisms proposed as to how Treg suppress immune responses(14, 15). It has been 
proposed that Treg cells can suppress immune response by repression of activated 
thymocyte proliferation in a cell contact dependent manner (16, 17). Additionally, there 
are other studies which show that suppressive cytokines, IL-10 and TGFβ, also induce 





Figure1.1 An overview of thymocyte differentiation  
Thymocyte development occurs in successive differentiation stages in which thymocytes 
localize to distinct thymic regions. The thymus is composed of cortical and medullary 
regions. Immature thymocytes (DN1-DN4) commit to the T cell lineage and initiate TCR 
gene rearrangements as they traverse the cortex. DP cells undergo positive selection in the 
cortex, signaling a transition to the SP stage. SP cells translocate to the medulla where they 
are subject to negative selection against numerous self-antigens, and then emigrate from 
the thymus to join the peripheral naïve T cell pool. 
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At both the DP and SP stages, thymocyte fate is dictated largely by signal strength 
of the TCR as it engages peptide:MHC complexes on surrounding stromal cells. DP 
thymocytes expressing TCRs with very weak to no affinity for self-peptide:MHC 
complexes undergoes “death by neglect”. This is because the level of TCR signaling is not 
sufficient to upregulate expression of pro-survival genes. High affinity TCR interactions at 
the DP and SP stages causes apoptosis, thus eliminating potentially auto-reactive cells 
before they have the opportunity to enter the periphery and cause autoimmunity (9). SP 
cells that encounter self-peptide:MHC complexes of intermediate affinities can undergo 
further maturation, or differentiation into the regulatory T cell lineage. However, the TCR 
affinity threshold that determines which cell fate is adopted, as well as other molecular 
signals that modulate this decision have not been clearly elucidated. Once thymocytes have 
matured completely in the medulla, they are exported from the thymus as naïve T cells and 
migrate into secondary lymphoid organs, where they may join the peripheral T cell pool 
and contribute to adaptive immune responses against pathogens and tumors.  
Each stage of thymocyte development is governed by signals delivered by thymic 
stromal cells. Thymic stromal cells reciprocally depend on signals from thymocytes for 
their maturation and maintenance. Thus, understanding the cellular and molecular signals 
that govern this bi-directional crosstalk is essential to our understanding of differentiation 
of a healthy, diverse, and self-tolerant T cell compartment.  
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1.2 THYMIC STROMAL CONTRIBUTION TO THYMOCYTE DEVELOPMENT 
1.2.1 Cortical Thymic Epithelial Cells 
cTECs are thymic epithelial cells localized within the cortical region of the thymus. 
They are phenotypically and transcriptionally distinct from thymic epithelial cells in the 
medulla and have a unique role in promoting thymocyte differentiation. cTECs are defined 
by the expression of cytokeratin–8/18, Ly51, MHCII, and Epcam (21, 22). Key roles 
played by cTECs include provision of signals that promote T-lineage commitment (23, 24) 
and positive selection (25). 
Thymocyte progenitors that enter blood vessels at the CMJ encounter a cTEC 
population expressing DLL4 to activate Notch signaling, which is required for T-lineage 
commitment. Thus, in the absence of Notch signals, thymocyte progenitors differentiate 
into NK cells or B cells (26). This has been shown in in-vitro culture assays using DLL1 
expressing OP9-DL1 cells, where hematopoietic cells develop into T cells and 
hematopoietic cells with no signal develop into B cells (26, 27). Furthermore, it has been 
demonstrated that cTECs provide DLL4, which is essential for commitment of pre-cursors 
to the T cell lineage (28). cTEC also express IL-7, and signaling through the IL-7R is 
required for survival and proliferation of thymocytes at DN3 and DN4 (6, 24, 29). 
In addition to providing survival and differentiation signals to DN thymocytes, 
cTECs have the unique capability of positively selecting DP thymocytes that express self-
MHC restricted TCRs. cTECs present peptides on both MHC-I and MHC-II molecules. 
There are several unique aspects of the proteolytic machinery that alters presentation of 
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self-peptides so as to promote thymocyte positive selection. Peptides presented by the 
MHC-I molecules are generated in the cytosol by the proteasome. Interestingly, cTECs 
express a unique catalytic proteosomal subunit β5t, that distinctly cleaves self-proteins to 
generate peptides for positive selection. (30, 31). In the absence of β5t, positive selection 
of CD8SP is impaired (31-33). In addition, replacing expression of β5t in cTECs with other 
proteasomal subunits that are not expressed by mTECs did not restore positive selection of 
CD8SP thymocytes (34). Together, these studies demonstrate that a unique pool of peptides 
generated by β5t is required for efficient positive selection of CD8SP thymocytes, although 
it is not understood why or how this peptide pool is specialized for this function. MHC-II 
peptide presentation is also uniquely regulated in cTECs, which express high levels of the 
serine protease TSSP and the lysosomal protease cathepsin L, which generate peptides 
required for efficient positive selection (35, 36). Thus, cTECs are required for positive 
selection of DP thymocytes with a diverse repertoire of TCRs that are both MHC-I and 
MHC-II restricted.  
 
1.2.2 mTEC 
mTECs are localized within the medulla region of the thymus and are responsible 
for presenting tissue restricted antigens to developing thymocytes, which is critical for 
negative selection. mTECs are defined as CD80+, EpCAM+, MHC-II+, and UEA-1+ through 
flow cytometry analysis and by Cytokeratin-5+ and Cytokeratin-14+ through 
immunohistochemistry (25). mTECs are subdivided into mTEClo (CD80lo MHC-IIlo) and 
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mTEChi (CD80hi MHC-IIhi) subsets which are functionally distinct in their capacity to select 
medullary thymocytes. Previously it was thought that all mTEClos were the precursors of 
mTEChis but recently it has been recently shown that the portion of mTEClo is ‘post-aire 
mTEC’ which indicate that mTEClos are a heterogeneous cell population (37, 38).  
Differentiation of mTECs in the medulla, which is essential for central tolerance, is 
regulated by crosstalk between thymocytes and mTEC progenitors. It has also been 
demonstrated that RANKL (Receptor activator of nuclear factor kappa-B ligand) on 
positively-selected thymocytes binds RANK on mTEClos, promoting mTEC maturation 
(39). Therefore, RANKL-deficient mice show a significant reduction in their number of 
mTECs and fail to establish self-tolerance (39, 40) Along with RANKL, it has been 
demonstrated that other ligands of the tumor necrosis factor superfamily (TFNSF) 
cytokines also contribute to mTEC differentiation, such as CD40L (40) and lymphotoxin 
(LT)(41) (25). Furthermore, TCR-mediated interactions between CD4+ T cells and self-
antigen-MHCII on mTECs play a pivotal role in promoting the expansion of mature 
mTECs in the medulla (42). This indicates that crosstalk between mTECs and T cells is 
necessary for mTEC maturation, and thus central tolerance. 
The medulla is a specialized microenvironment for enforcing self-tolerance of 
maturing T cells, and thus, preventing autoimmune disorders. In order to educate 
thymocytes against auto-reactivity, mTECs have the unique ability to express a broad range 
of self-proteins otherwise expressed only in terminally-differentiated organs, such as the 
eye or pancreas. These tissue restricted antigens (TRAs), such as insulin and albumin (43) 
have no functional role in mTEC cellular biology, but when presented on the cell surface 
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in the context of MHC serve to delete auto-reactive SP cells. SP cells accumulate in the 
medulla, where they rapidly scan the antigenic library expressed on medullary APCs. SP 
cells with high affinity for self-antigens undergo apoptosis in a process referred to as 
negative selection. TRA expression on mTECs is promoted by the transcriptional regulator 
AIRE, which promotes low-level expression of genes that are epigenetically silenced in 
TECs (44, 45). Mutations in AIRE have been identified in APECED (autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy) patients, who suffer from multi-
organ autoimmunity, as do AIRE-deficient mice, indicating that AIRE is essential for 
enforcing mTEC TRA expression and establishing self-tolerance (46, 47). However, over 
half of TRAs are AIRE independent, suggesting complementary mechanisms for inducing 
TRAs in mTECs (48-50). AIRE is expressed in the more differentiated mTEChi subset, as 
opposed to mTEClo cells. Recent studies using single cell RNA transcriptome analysis have 
identified that 95% of the reported TRA are expressed by mTECs (51). However, only 1-
3% of Aire+ mTEChi cells are stochastically expressing each Aire dependent TRA at a given 
time (50, 52). Therefore, it is important that SP thymocytes must efficiently scan TRAs in 
the medulla to encounter the full range of auto-antigens to eliminate thymocytes expressing 
self-reactive TCRs.  
 
1.2.3 Dendritic cells and their role in negative selection 
In addition to TECs, dendritic cells are the other major antigen presenting cell 
subset in the thymus, (53). There are two types dendritic cells in the thymus, plasmacytoid 
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DCs (pDCs) and conventional DCs (cDCs). pDCs are defined by the expression of 
CD45RA+, PDCA1+, B220+, and CD11cmid. cDCs are defined by CD11chi, MHCII+, and 
CD45RA-. cDCs can be further divided into signal regulatory protein-α+(Sirpα) DCs and 
Sirpα-DCs, which are defined as Sirpα+ CD11b+ CD8- and Sirpα- CD11b+ CD8+ DCs, 
respectively (54).  
All dendritic cells originate from hematopoietic progenitors in the bone marrow 
(55). Within the thymus, Sirpα-DCs have been shown to develop from intrathymic 
hematopoietic progenitors (56-59). Additional studies using congenically marked 
parabiotic mice and cell transfer experiments have demonstrated that. the other two DC 
subtypes, pDCs and Sirpα+DCs, are recruited to the thymus from the periphery (60). 
Accordingly, Sirpα-DCs are known as resident DCs and Sirpα+DCs are called migratory 
DCs (30).  
Thymic DCs are critical for the induction of negative selection and Treg generation. 
Mice lacking MHC-II in bone marrow derived APCs have an accumulation in CD4SP cells 
in the thymus, reflecting impaired deletion of autoreactive cells (61, 62). CD11c depleted 
mice have comparably impaired negative selection, with severe autoimmune consequences 
(63). Previous studies have also shown that MHC-II deficient APCs result in impaired Treg 
induction (64-66). In addition, to presenting self-peptides derived from their own proteome 
to induce tolerance, DCs also present TRAs to thymocytes. DCs don’t express AIRE; 
instead, they acquire TRAs from mTEChi cells, although the mechanisms of transfer are 
incompletely understood (67, 68) (64). Furthermore, antigens presented by dendritic cell 
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are also acquired from the blood and other peripheral tissues (58, 69-71). Sirpα+DCs are 
able to sample antigens from the bloodstream and migrate into the thymus, which is mostly 
mediated by CCR2. (70, 71) By contrast, thymic Sirpα-DCs present antigens from mTEC 
more efficiently than Sirpα+DCs. Their localization in the medulla is guided by Xcr1 (66, 
72). Given the distinct self-antigens displayed by multiple DC subsets, SP thymocytes also 
must scan many DCs, in addition to mTECs, during their residence in the medulla to 
encounter the full range of displayed auto-antigens.  
 
1.3 CONTRIBUTION OF CHEMOKINE RECEPTORS TO CENTRAL TOLERANCE INDUCTION 
IN THE THYMUS  
If T cells do not enter the medulla or interact with APCs, autoimmunity will ensue; 
therefore, it is important to elucidate the cellular and molecular mechanisms that influence 
SP medullary entry and scanning of APC subsets therein. The importance of medullary 
entry for central tolerance is exemplified by studies of CCR7-deficient mice. CCR7 is a G 
protein-coupled receptor that is upregulated after positive selection. CCL19 and CCL21, 
ligands for CCR7, are expressed by mTECs, and lead to accumulation of SP cells in the 
medulla (73). 2-photon imaging have revealed that CCR7 contributes to chemotaxis of SP 
cells towards the medulla as well as their rapid motility (74). Because many CCR7-
deficient thymocytes are aberrantly localized to the cortex, they do not efficiently interact 
with medullary APCs in the medulla, resulting in failed central tolerance and eventual 
autoimmune diseases (75). These findings indicate that entering and accumulating with the 
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medulla and interacting efficiently with mTECs and DCs therein is vital for the formation 
of self-tolerance. Indeed, a previous study showed that thymocytes in Mst1-/- mice migrate 
slowly and have impaired interactions with mTECs in the context of CCR7 signaling, 
resulting in incomplete negative selection (76). While CCR7 is an essential mediator of 
medullary entry and central tolerance induction, our data indicates that additional GPCRs 
contribute to these processes. Pertussis Toxin (PTX) inhibits signaling through 
heterotrimeric G proteins, and treatment with PTX disrupts the migration of lymphocytes 
via GPCRs, including chemokine receptors. While PTX treatment abolished thymocyte 
medullary entry, CCR7-deficiency merely diminishes the accumulation of SP thymocytes 
within the medulla, indicating other GPCRs promote thymocyte medullary entry. Recently 
our lab demonstrated a role for CCR4 in DP CD69+ thymocyte migration, suggesting that 
CCR4 is vital for medulla entry of DP CD69+ thymocytes. However, CCR4 deficient cells 
do not completely block medulla entry. These findings indicate that cooperation of GPCRs 
acts synergistically to enforce efficient medullary entry, and thus central tolerance (74). It 
has also recently been shown that though Ccr4-/-Ccr7-/- SP cells are defective in entering 
the medulla, some are able to migrate in, suggesting additional chemokine receptors 
contribute to their medullary migration (77).  
Once thymoyctes enter the medullary region, they have to migrate rapidly to scan 
mTECs and DCs displaying the full spectrum of diverse TRAs. Two-photon imaging has 
revealed that medullary thymocytes migrate faster than those in the cortex and make 
frequent, transient contacts with DCs (67, 74, 78) While DP and CD4SP in the cortex 
migrate at 5µm/min and 14.3µm/min, respectively, CD4SP in the medulla migrate at a 
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speed of 16µm/min (76) and contact approximately 500 DCs in the medulla (79). It is likely 
that the rapid motility of SP cells in the medulla promotes efficient scanning all of the self-
antigens presented within the medulla. Thus, it is also important to evaluate the 
contribution of candidate GPCRs to rapid motility, as well as medullary entry and 
accumulation of post-positive selection thymocytes. 
 
1.4 THE CONTRIBUTION OF THYMIC STROMAL CELLS TO AGE-ASSOCIATED THYMIC 
INVOLUTION 
Involution of the thymus with age is a well-established phenomenon, which 
contributes to a decline in immune responses in aged individuals. The thymus in mice 
begins to involute after 6weeks of age, when the thymus reaches its maximum size. The 
thymic atrophy causes the decease in naïve T cell output (80, 81). The turn-over rate and 
number of TECs decreases progressively with age during thymic involution (82). The 
expression of Foxn1, a transcription factor required for TEC differentiation, declines with 
age in mice (83-87), and is thought to be a major factor regulating thymic involution.  
Additionally, organismal senescence results in abnormal thymic stromal organization (86, 
88, 89). Even though it has been shown that the proliferation rate of thymocytes in the 
thymus declines with age, it was unclear whether the dysfunctional phenotype of aged 
thymocytes is caused by intrinsic or extrinsic defects. One recent study has indicated that 
an aged thymic microenvironment contributes to the aging process, as transplantation of 
old bone marrow into young mice enables the generation of functional thymocytes (90). 
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Another study demonstrated that a reduction of androgen hormone helps regenerate aged 
thymus and enhances T cell function (81, 91). While castration results in larger thymuses 
in older mice, it does not completely halt thymic involution, suggesting that other 
mechanisms are at play (92). A recent study has also shown that transplantation of young 
colony-forming thymic epithelial cells into 9 to 12 month-old mice resulted in partially 
rejuvenating the thymus, ultimately leading to normal T cell production. However, the 
circulating components from young mice by heterochronic parabiosis is not sufficient to 
rescue aged thymus (93). Yet another study showed, transduction of cyclin D1 and 
inactivation of Rb family proteins restores thymic mass in aged mice (94, 95). Despite 
many studies producing a partial restoration of thymus function in aged mice, the 
mechanisms by which involution occurs in the aging thymus remain elusive. 
 
1.5 DISSERTATION OBJECTIVE 
 
Elucidation of age associated thymic stromal changes during thymic involution by 
global transcriptional analysis of thymic stromal subsets  
Age associated thymic involution results in impaired thymic structure, reduction of 
thymocyte output, and lowered T cell function, which leads to decreased immune function 
and infections (5, 89, 96). Given that crosstalk between thymocytes and thymic stroma 
cells is critical for thymocyte development, these reduced immune functions may be 
partially due to changes in the thymic microenvironment. Elucidation of molecular 
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mechanisms underlying thymic involution may ultimately lead to therapies that could 
rejuvenate immune capabilities in older individuals.  
To identify such molecular mechanism, we analyzed transcriptomes of thymic 
stromal subsets during early thymic involution. Interestingly, genes differentially 
expressed in older mice were mostly found in mTEClo, Sirpα-DC, and Sirpα+DCS, but not 
in cTEC, mTEChi or fibroblast populations. Our data suggests that the expression of cell 
cycle related genes were decreased in mTEClo. Further analysis showed that E2F3, which 
controls cell cycle progression, target genes are downregulated in 6month of thymic 
epithelial cells especially in cTEC and mTEClo. Additionally, pro-inflammatory genes in 
DC and DCS were increased with age. One of those proinflammatory cytokine, IL-1 is 
known to promote thymic atrophy (97), which suggests that thymic dendritic cells 
contributes to thymic involution. Out data expands the knowledge on the etiology of age 
associated thymic involution     
 
Understanding the role of EBI2 and GPR146 in thymocyte development 
 
Throughout thymocyte development, thymocyte progenitors undergo bidirectional 
crosstalk with the thymic epithelial cells, which is important for proper development of 
both the thymocyte and epithelial subsets. Chemokine receptors, a subset of G protein 
coupled receptors (GPCRs), have been implicated in guiding thymocytes into the different 
thymic regions, thus enabling the required interactions with different stromal subsets. 
Notably, failure of thymocytes to enter the thymic medulla resulted in deformation of 
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medullary thymic epithelial cells, which are important for presenting TRAs and eliminating 
self-reactive thymocytes through negative selection. To identify GPCRs that contribute to 
thymocyte medullary entry and are important for central tolerance, we performed 
transcriptome analysis. Based on expression profiling, we identified EBI2 and GPR146 as 
candidate GPCRs that could contribute to thymocyte medullary entry and/or negative 
selection.  
Our study has found that EBI2 is required for negative selection in response to low 
level of endogenous antigens. Additionally, EBI2 deficiency alters the cell fate decision in 
favor of Treg generation over negative selection in response to higher affinity antigens.   
Along with this, we found that Ebi2-/- mice showed altered TCR repertoire. Further analysis 
showed that EBI2 contributes to rapid motility and accumulation of CD4SP in medulla, 
which are important for efficient negative selection of thymocytes.  
In order to determine the role of GPR146 in thymocyte development, we 
successfully generated Gpr146-/- mice. Furthermore, analysis on Gpr146-/- mice revealed 
that Gpr146-/- cells showed high cellularity than Gpr146+/+, when bone marrow cells were 
transferred to reconstitute the thymus in a competitive condition. This suggests new and 
potential roles of GPR146 in thymocyte development.  
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Chapter 2:  Global transcriptional profiling reveals distinct functions 
of thymic stromal subsets and age-related changes during thymic 
involution 
The contents of the chapter are modified from Cell reports, 9(1), pp.402–415. 
Sanghee Ki, Daechan Park, Hilary J. Selden, Jun Seita, Haewon Chung, Jonghwan Kim, 
Vishwanath R. Iyer, Lauren I. R. Ehrlich, 2014. Global transcriptional profiling reveals 




Age-associated thymic involution results in diminished T cell output and function 
in aged individuals. However, molecular mediators contributing to the decline in thymic 
function during early thymic involution remain largely unknown. Here we present 
transcriptional profiling of purified thymic stromal subsets from mice 1, 3, and 6 months 
of age, spanning early thymic involution. The data implicate novel biological functions for 
a subset of thymic epithelial cells. The predominant transcriptional signature of early 
thymic involution is decreased expression of cell cycle associated genes and E2F3 
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transcriptional targets in thymic epithelial subsets. Also, expression of pro-inflammatory 
genes increases with age in thymic dendritic cells. Many genes previously implicated in 
late involution are already deregulated by 3 to 6 months of age. We provide these thymic 
stromal datasets, along with thymocyte datasets, in a readily searchable web-based 
platform, as a resource for investigations into thymocyte: stromal interactions and 
mechanisms of thymic involution. 
 
2.2 INTRODUCTION 
The thymus is spatially organized into cortical and medullary regions, containing 
heterogeneous stromal cells, including thymic epithelial cells (TECs), dendritic cells, 
macrophages, fibroblasts, and endothelial cells (98). As thymocytes mature, they migrate 
through distinct thymic microenvironments, where they undergo bi-directional crosstalk 
with local stromal cells, essential for the generation of a diverse, and self-tolerant T cell 
pool (6). Signals provided by developing thymocytes are also required for differentiation 
and maintenance of thymic stromal cells (99). While some molecular signals responsible 
for this bidirectional signaling have been characterized, many remain to be identified. 
Thymocyte:stromal cell crosstalk first occurs in the cortex where thymocyte 
progenitors encounter cortical TECs (cTECs) that express NOTCH1 ligands, SCF, and IL-
7, which are essential for thymocyte survival, proliferation and commitment to the T cell 
lineage (6, 100). In addition, cTECs display self-peptide:MHC complexes that promote 
positive selection of self-MHC restricted thymocytes, and apoptosis of autoreactive cells 
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(101). Reciprocally, unidentified signals from early thymocyte progenitors are critical for 
cTEC differentiation (22). 
 Following positive selection, thymocytes migrate into the medulla where they 
interact with medullary thymic epithelial cells (mTECs). mTECs can be subdivided into 
mTEClo and mTEChi subsets, based on differential expression of CD80 and MHC class II. 
The mTEChi subset expresses the chromatin modulator AIRE, which promotes expression 
of tissue-restricted antigens (TRAs), genes otherwise expressed in a limited number of 
differentiated tissues, such as the pancreas or retina (44, 102) . When medullary thymocytes 
engage TRAs on mTECs, they undergo apoptosis or differentiate into regulatory T cells, 
thus establishing central tolerance to peripheral self-antigens. Conversely, mTEClo cells 
must engage thymocytes entering the medulla, via tumor necrosis factor superfamily 
members, to drive differentiation to the mTEChi stage (99). Thus, bi-directional signaling 
in the medulla between TECs and maturing thymocytes is critical for thymocyte tolerance 
and medullary stromal organization. 
Thymic dendritic cells also play a critical role in central tolerance. Conventional 
thymic dendritic cells can be subdivided into Sirpα-CD8+CD11b- (DC) and Sirpα+CD8-
CD11b+ (DCS) subsets (60). Thymic dendritic cells can acquire TRAs from mTECs to 
mediate deletion of autoreactive thymocytes (102). In addition, DCS traffic peripheral 
antigens into the thymus to mediate negative selection or induction of regulatory T cells 
(57, 65). Thymic dendritic cells require chemotactic signals from mTECs to accumulate in 
the medulla and function properly (72), underscoring the complex interplay between 
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thymocytes and various stromal subsets required to ensure production of a self-tolerant T 
cell repertoire.  
The thymus involutes in an age-dependent manner, resulting in diminished TEC 
cellularity and turn-over (82), disrupted thymic architecture, decreased thymic output, and 
reduced T cell function (5, 89, 96). Both hematopoietic age-related dysfunction and 
degeneration of the thymic stromal compartment likely contribute to thymic involution (96, 
103). While reduced levels of the transcription factor Foxn1 contribute to TEC atrophy 
(86), and genetic manipulation of cell-cycle regulators can maintain thymic mass in aged 
mice (94, 95), specific molecular pathways driving degeneration of the thymic stroma early 
in the process of involution remain to be discerned. Furthermore, while manipulation of 
sex steroids or growth factor levels in aged individuals can transiently increase thymic size 
(91, 104), the resultant thymi are not functionally equivalent to young thymi, and may be 
incapable of maintaining central tolerance (92). Thus, identifying molecular pathways that 
regulate stromal changes associated with involution remains an important goal.  
Here we present global transcriptional profiling of purified thymic stromal subsets 
from mice at 1, 3, and 6 months of age, enabling the community to query stromal subset-
specific gene expression before and during early thymic involution. Griffith et al. 
previously reported transcriptional profiles of non-sorted thymic stroma from the cortex, 
medulla and cortico-medullary junction, enabling evaluation of regionalized gene 
expression in young and aged thymi (92, 105). The current resource provides 
complementary information about gene expression in specific stromal cell types during 
early thymic involution. Our data reveal predicted, as well as unexpected expression of 
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genes in different thymic stromal subsets that suggest novel stromal cell functions. 
Interestingly, decreased expression of cell-cycle genes and downregulation of E2F3 
activity are major hallmarks of early thymic involution in the TEC compartment. 
Upregulation of proinflammatory genes in thymic dendritic cell subsets also occurs over 
this time course. Analysis of genes previously implicated in late thymic involution reveals 
some of these factors may contribute to early involution, while others are likely sequelae 
of the aging process. To facilitate use of this resource, we provide our thymic stromal gene 
expression data, along with our previous thymocyte transcriptional profiling data, as an in 
silico model in the readily searchable web-based platform Gene Expression Commons 
(GExC) (106)  (https://gexc.stanford.edu/model/475). Exploration of our datasets on this 
user-friendly interface will enhance elucidation of the molecular pathways mediating 
thymocyte-stromal cell crosstalk and age-associated thymic stromal changes.  
 
2.3 EXPERIMENTAL PROCEDURES 
 
Mice 
C57BL/6J mice were housed at the UT Austin animal facility, under conditions 
approved by the Institutional Animal Care and Use Committee.  
 
FACS isolation of thymic stromal subsets and transcriptional profiling 
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Thymi from 1, 3, and 6-month-old male C57Bl/6J mice were digested with 
Collagenase D (Roche, Switzerland), followed by Collagenase/Dispase (Roche) in the 
presence of DNase I, as described previously(107). Cells were immunostained with FITC-
conjugated Ulex europaeus agglutinin I (UEA-1) (Vector Laboratories) and the following 
fluorochrome-conjugated antibodies (eBioscience or BioLegend, unless indicated): 
EpCAM (G8.8), TER-119 (TER- 119), CD11c (N418), CD31 (390), Sirpα (P84), B220 
(RA3-6B2), I-A/I-E (M5/114.15.2), CD80 (16-10A1), CD45 (30-F11, BD Biosciences), 
and biotinyated Ly-51 (6C3). Stromal subsets were FACS purified by double sorting to 
>95% purity on a FACSAria (BD Biosciences); data were analyzed with FlowJo (Treestar).  
 
Sample preparation and transcriptional profiling 
Stromal subsets were collected directly in 1ml of TRIzol (Life Technologies), and 
RNA was purified. 1µg of high-quality total RNA was amplified, converted to cDNA using 
the two-cycle cDNA synthesis protocol, labeled, and hybridized onto Mouse Genome 430 
2.0 arrays (Affymetrix) at the Stanford PAN facility core according to Affymetrix’s 
specifications. CEL files were uploaded to GExC(106, 108), where the data were 
normalized using the RMA algorithm (108) for normalization. An in-silico model of gene 
expression data from thymic stromal subsets and previous thymocyte subsets (GSE34723) 
(106, 108) is available (https://gexc.stanford.edu/model/detail/475). Thymic stromal 
expression data have been deposited in GEO (GSE56928). 
 
Bioinformatics analysis  
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R (version 2.15.2) was used for hierarchical clustering (function “hclust”) and DEG 
identification (package “limma” version 3.14.4) (109). p-values were adjusted using the 
Benjamini–Hochberg procedure to correct for multiple comparisons, and an adjusted p-
value of 0.01 and a fold change of 2 were used as cut-offs for DEG. Subtype-specific DEGs 
were defined as genes differentially expressed in all pairwise comparisons with other 
subsets of the same age. Age-associated DEGs were defined as the union of differentially 
expressed genes from pairwise comparisons of single stromal subsets compared at different 
ages. To identify Aire-regulated genes in mTEChi cells, we analyzed Aire deficient and 
wild-type mTEChi expression data from the following datasets using R (package “affy” 
version 1.36.1): GSM49731, GSM49732, GSM49735, GSM49736 (48, 110). We defined 
the top 400 DEGs, ranked according to fold change, as Aire-regulated genes. Probe IDs 
were annotated using version 33 of these array platforms, and gene symbols were then 
compared to our mTEChi DEG list to identify the extent of overlap. TRAs identified on the 
basis of unique tissue expression (92) were also compared to our mTEChi DEG list for 
overlap.  
PCA was performed with the “princomp” function in MATLAB R2012b, and 
Cluster 3.0 was used for K-means clustering. For Gene Ontology analysis, DAVID version 
6.7 was used with probe Ids (111). GSEA was carried out by searching Molecular Signature 
Database (MSigDB) version 4.0 provided by the Broad Institute 
(http://www.broad.mit.edu/gsea/) (112). When multiple probe IDs mapped to a gene 
symbol, the maximum probe value was used for GSEA. For identification of aging 
associate gene sets, 1:3:6 was used for phenotype labels of ages 1, 3, and 6 months to 
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calculate Pearson correlations, and then the immunologic signatures (C7) and the curated 
gene sets (C2) of the MSigDB gene sets were queried. A nominal (NOM) p-value cut-off 
was applied to the results from C7. Boxplots were generated after converting human genes 
into mouse orthologs using the mouse annotation from Mouse Genome Informatics (MGI) 
released April 4, 2012. Statistical significance was determined using paired Student's t-
tests. 
 To generate heat maps, log2-transformed expression intensities were 
centered on the mean (defined as zero) for each probe to compare relative expression across 
subtypes and ages.  
 
RT-PCR on the Fluidigm platform 
For each FACS sorted stromal subset, cDNA was synthesized from 300ng RNA 
using qScriptTM cDNA SuperMix (Quanta). cDNAs were diluted and preamplified with 
2X Taqman preamp Master Mix (Applied BioSystems), using a pool of custom primers for 
transcripts of interest. qPCRs were carried out on cDNA distributed on 48.48 Dynamic 
Arrays, using primers for genes of interest on a BioMark System according to 





2.4.1 Transcriptional profiling of thymic stromal subsets at 1, 3, and 6 months of age 
We FACS purified thymocyte stromal subsets from mice over the course of early 
thymic involution to identify subtype specific and age-regulated transcriptional profiles. 
Thymic cTEC, mTEClo, mTEChi, DC, DCS, and fibroblast populations were FACS purified 
from C57BL/6J male mice at 1, 3 and 6 months of age as follows: cTEC (Epcam+CD11c-
UEA1-MHCII+Ly51+), mTEClo(Epcam+CD11c-UEA1+ MHCIIlo CD80lo), mTEChi 
(Epcam+CD11c-UEA1+MHCIIhiCD80hi), DC (MHCII+Epcam-CD11c+Sirpα-CD80+), DCS 
(MHCII+Epcam-CD11c+Sirpα+CD80+), and fibroblasts (MHCII-CD45-Ter119-CD31-) 
(Figure 2.1A). During the sort setup, we ensured that all Epcam+ TECs were included in 
the initial MHCII+ gate (Figure 2.1B). Purified mRNA from biological duplicates of each 
subset at each age was analyzed on Affymetrix Mouse 430 2.0 microarrays. Resultant data 
were uploaded to the GExC platform for normalization (106), and resultant normalized 
signal intensity values were used for all subsequent bioinformatics analyses herein.
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Figure 2.1 Gating schemes for FACS sorted thymic stromal subsets  
(A) Strategy for sorting thymic stromal subsets (gated on live events; frequencies within 
gates displayed). (B) Backgating analysis of the EPCAM+CD11c- TEC population gated 
in the panel on the right demonstrates that the majority of TECs are within the MHCII+ 
gate in the left panel. Comparable backgating was used to adjust the MHCII+ gate during 
the initial sort setup to ensure MHCIIlo TECs were not excluded during cell sorting. Red 
events on the left panel represent cells gated as EPCAM+CD11c- in the absence of the 
MHCII+ gate displayed in the left panel.   
 28 
To assess consistency between duplicate datasets and to globally compare 
transcriptional profiles between stromal subsets, we performed unsupervised hierarchical 
clustering and principal components analysis (PCA) on the 30% of genes most variable in 
expression across subsets (Figure 2.2A and 2.2B). Duplicate datasets clustered closely 
together, indicating reliability of the data. Stromal subtypes clustered together regardless 
of age (Figure 2.2A), demonstrating that each stromal subset maintains its transcriptional 
identity during thymic involution. Stromal subsets at 6 months of age were further from 
their 1 and 3 month counterparts, indicative of age-related transcriptional changes in the 
data. Interestingly, age-associated changes were implicated not only in TEC subsets, which 
have been suggested to be drivers of involution, but also in dendritic cells and fibroblasts. 
Overall, PCA was consistent with hierarchical clustering (Figure 2.2B), and showed that 
mTEChi were distal to other TEC subsets, likely due to expression of diverse TRAs. As 
expected, dendritic cell subtypes clustered together, while fibroblasts were distinct from 
other stromal subsets.  
To validate our data, we queried genes previously reported to be differentially 
expressed in distinct stromal subsets (Figure 2.2C). TECs expressed cytokeratins and the 
transcription factor Foxn1, confirming their identity (22, 113). As expected, cTEC and 
mTEClo expressed high levels of Il7 (114, 115), while Ccl25, Cxcl12, Dll4, Enpep/Ly51, 
Ly75/CD205, and Psmb11/β5t were predominantly expressed by cTECs (31, 116, 117). 
Aire, Cldn3, and Cldn4 were expressed specifically in mTEChi cells, as expected (118). 
MHCII genes were expressed by dendritic cells and TECs, consistent with their roles in 
antigen presentation, while dendritic cells and mTEChi expressed high levels of Cd80 and 
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Cd86. ItgaX (CD11c) was expressed uniquely by dendritic cells, with Sirpα and Xcr1 (72) 
expressed uniquely in the DCS and DC subsets, respectively. Fibroblasts expressed Pdgfrα 
and Pdgfrβ, and the extracellular matrix (ECM) component Col6a3, as anticipated for 




Figure 2.2 Expression profiling of thymic stromal subsets. 
(A) Hierarchical clustering and (B) PCA were carried out on the top 30% of genes most 
variable in expression. Each symbol in the PCA represents a single array. (C) Expression 
of known thymic stromal subset-specific genes is presented as a heat map, using the 
average of biological duplicates for each subset. Probesets with a dynamic range ≥ 3 (in 





























































































































































































































































































































































































To further validate our data, we sorted an additional biological replicate of thymic 
stromal subsets from mice 1 month of age, and confirmed subset-specific expression of 25 
genes by qRT-PCR analysis on the Fluidigm platform (Figure 2.3). Together, these 
analyses validate the datasets, and demonstrate that thymic stromal subset identity is 
maintained during aging.
 
Figure 2.3 Confirmation of expression profiling data. 
(A) To confirm the microarray expression profiling data, 3 - 4 genes identified as DEGs in 
each subset were chosen for validation by high throughput qRT-PCR (Fluidigm) on an 




























































































2.4.2 Differentially expressed genes suggest distinct functions of thymic stromal 
subsets 
We identified differentially expressed genes (DEGs) in each stromal subset as those 
genes uniquely up- or down-regulated by >2 fold relative to all other stromal subsets of the 
same age, with an adjusted p-value <0.01. As expected from PCA analysis, mTEChi and 
fibroblast subsets had the most unique DEGs at each age (Figure 2.4A). We next 
investigated common functional characteristics of unique DEGs in each subset. The top 
Gene Ontology (GO) term hit for DEGs from 1-month old fibroblasts was ‘cell adhesion’, 
with ‘extracellular matrix’ appearing as well, suggesting that although fibroblasts were 
sorted based on the absence of markers in other subsets, the population is greatly enriched 
in mesenchymal cells. A heat map of genes in the GO term ‘cell adhesion’ category, reveals 
ECM components and integrins that are likely relevant substrates for adhesion and 




Figure 2.4 Mesenchymal signature of fibroblasts revealed by DEGs 
(A) The number of stromal subset-specific DEGs, identified by pair-wise comparisons 
between stromal subsets of the same age, is displayed. (B) The heat map displays the 
relative expression of all up-regulated DEGs from 1-month fibroblasts that overlap with 







































































































































































































































































The large number of DEGs and dissimilarity in overall transcriptional relatedness 
of mTEChi relative to other stromal subsets (Figures 2.4A) may have been due to expression 
of diverse TRAs (43). To address this possibility, we identified Aire-regulated genes by 
analyzing published expression data from Aire deficient versus wild-type mTEChi cells 
(48). After excluding genes not shared between microarray platforms, we compared the list 
of Aire-regulated genes to mTEChi up-regulated DEGs. Of the 560 mTEChi up-regulated 
DEGs, only 150 (37%) were Aire-regulated (Figure 2.5A), suggesting many mTEChi DEGs 
are Aire-independent. Furthermore, comparison against a list of TRAs identified on the 
basis of limited tissue expression (92), revealed overlap with only 9% of mTEChi DEGs 
(Figure 2.5B). Thus, many mTEChi DEGs may have a biological function, rather than 
serving as TRAs. Interestingly, the top GO hit term for 1 month mTEChi DEGs was 
‘defense response’ (p-value: 8x10-7), which included chemokines (Ccl20, Cxcl13, Cxcl3), 
defensins (Defb19, Defb3, Defb5, Defb6, Defb8, Defa21, Defa22), and cytokines (Il1f6, 
Il23a, Il5) (Figure 2.5C). Only 15 of 55 defense response genes were identified as TRAs 
(not shown). Thus, mTEChi cells may promote defense responses in the thymus. Consistent 
with a unique biological state of the mTEChi subset, AIRE has been shown to regulate 






Figure 2.5 Defense response function of mTEChi revealed by DEGs. 
(A) Overlap between Aire-regulated genes (48) and 1 month mTEChi up-regulated DEGs, 
shared between microarray platforms. (B) Overlap between TRAs (92) and 1 month 
mTEChi up-regulated DEGs. (C) A heat map displaying the relative expression of up-



























































































































































Because of the transcriptional relatedness of cTEC to mTEClo and DC to DCS 
(Figure 2.2A-B), few DEGs were identified in these subsets (Figure 2.4A). Although these 
DEGs are likely important for the unique biology of these subsets (Figure 2.6A), the 
number of DEGs was too low to proceed with downstream bioinformatics analyses.
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Figure 2.6 Unique DEGs in cTEC, mTEClo, DC and DCS subsets. 
(A) The heat map displays the relative expression of select genes identified as unique 


















































































































































































































































































































































































































































































































































Therefore, we identified additional DEGs in cTEC after omitting mTEClo, and in 
DC after omitting DCS from the comparisons, and vice versa (Figure 2.7A-B). GO 
analyses of these DEGs confirmed epithelial characteristics of cTEC and mTEClo subsets 
(Figure 2.8). The “epithelium development” and “cell adhesion” terms contained 
previously known as well as unreported genes in cTEC and mTEClo subsets (Figures 2.9), 
including several genes involved in Wnt signaling, such as Wnt4 and the receptors Fzd2 
and Fzd3 (consistent with Bredenkamp et al., 2014; Griffith et al., 2012). Fgfr2 likely 
regulates TEC cellularity, as its ligand KGF causes transient thymic regeneration in aged 
mice (104). Cldn8 was expressed in cTECs, while Cldn9 and Cldn12 were expressed in 
cTEC and mTEClo subsets, demonstrating TEC subset specificity of claudin family 
members, consistent with expression of Cldn3 and Cldn4 in mTEChi cells (118). The top 
hit from GO analyses of DC and DCS DEGs was ‘immune response’ (Figure 2.8), 
including Toll like receptors, cytokines, and chemokines (Figures 2.10), consistent with 









Figure 2.7 Additional DEGs of cTEC, mTEClo, DC, and DCS 
(A) The graph depicts the number of cTEC and mTEClo DEGs identified before and after 
excluding each other during the analysis. The blue bars show the original number of DEGs 
when all subsets were compared in pairwise comparisons, while the red bar shows the 
number of additional DEGs newly identified after omitting the indicated subtype from the 
analysis. (B) The graph depicts the number of DC and DCS DEGs identified before and 






























































































































































































































































































































































































































Figure 2.8 Epithelial identity of cTEC/mTEClo and immune response function of 
DC/DCS revealed by DEGs. 
(A) GO term analyses of DEGs from cTEC/ mTEClo confirm the epithelial identity of 
these subsets. GO term analyses of DEGs from DC/ DCS confirm the immune response 
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Figure 2.9 Epithelial identity of cTEC/mTEClo revealed by DEGs. 
The heat maps display the relative expression of all genes in the (A) ‘epithelium’ and 
‘epithelium development’ GO terms and (B) ‘cell adhesion’ GO term that overlapped 

































































































































































































































































































Figure 2.10 Immune response function of DC/DCS revealed by DEGs. 
The heat maps display the relative expression of all genes in the ‘immune response’ GO 





























































































































































































































































































2.4.3 Thymic involution is associated with down-regulation of cell cycle genes in the 
mTEClo subset and decreased activity of E2F3 in cTEC and mTEClo cells 
 
Thymocyte and thymic stromal cellularity are greatest in mice around 1 month of 
age and subsequently decline as the thymus involutes (82). To evaluate transcriptional 
changes associated with early thymic involution, we compared gene expression in stromal 
subsets from mice at 1, 3, and 6 months of age. We identified aging-associated DEGs as 
those genes modulated by ≥ 2 fold, with an adjusted p-value ≤ 0.01 in pairwise comparisons 
of each subset at the three ages. Using these criteria, no aging-associated DEGs were 
identified in fibroblasts or cTECs, with only 1 DEG in mTEChi (Igha). In contrast, a 
significant number of DEGs were identified in DC, DCS, and mTEClo subsets (Figure 
2.11A). Over 90% of the DEGs in DC and DCS were up-regulated with age, whereas DEGs 
in mTEClo were both up- and down-regulated with similar frequencies. We conducted K-
means clustering on DEGs from each subset to identify groups of genes up- or down-
regulated as aging progresses from 1 through 6 months of age. Cluster 3 from mTEClo 
contained genes progressively and significantly down-regulated with age (Figure 2.11B-
C). We performed GO term analyses on each cluster to identify biological functions 
associated with age-related changes, and found significant hits only for mTEClo cluster 3. 
Genes in this cluster were associated with the cell cycle (Figure 2.11D), implicating a 
progressive decrease in expression of cell cycle regulators, such as Aurkb, Cdc20, Cdc6, 








Figure 2.11 Cell cycle genes are significantly down-regulated in mTEClo subsets in early 
thymic involution. 
(A) The number of up- or down-regulated DEGs identified from pairwise comparisons of 
stromal subsets at different ages is shown. (B) The heat map displays K-means clustering 
of all age-associated DEGs identified in the mTEClo subset. (C) The boxplot displays 
expression levels of mTEClo DEGs in cluster 3 from B, which are progressively down-
regulated with age (p-value < 2.2 x 10-16). (D) The top 5 GO term hits from cluster 3 of 
mTEClo DEGs reveal down-regulation of cell-cycle associated genes during aging. (E) 
The heat map displays the relative expression of down-regulated age-associated DEGs in 













































































































































We next utilized gene set enrichment analysis (GSEA) to identify aging-associated 
gene sets, without imposing an arbitrary fold-change cutoff. Strikingly, E2F3 target genes 
(121) were significantly down-regulated with age in both cTEC and mTEClo subsets 
(Figure 2.12A). This decline was gradual in mTEClo cells from 1 to 6 months, but 
precipitous in cTECs between 1 and 3 months (Figure 2.12B). E2F3 is a transcription factor 
critical for normal cellular proliferation (122), and many target genes are regulators of the 
cell cycle, such as Cdc6, Ccna2, Aurka, and Cdc7 (Figure 2.12C). Together, these analyses 
suggest that a decline in E2F3 activity results in decreased cell-cycle progression in cTEC 
and mTEClo cells, likely contributing to the decline in TEC cellularity early in the process 







Figure 2.12 E2F3 target genes are significantly down-regulated in mTEClo and cTEC 
subsets in early thymic involution. 
(F) GSEA reveals expression of E2F3 target genes is down-regulated with age in mTEClo 
and cTEC subsets. (cTEC NOM p-value < 10-3 NES=-2.48; mTEClo NOM p-value < 10-3, 
NES=-3.39) (G) The boxplot shows expression levels of E2F3 target genes in stromal 
subsets at 1, 3, and 6 months of age. Decreased expression of E2F3 target genes is apparent 
in aging cTEC and mTEClo subsets. (H) Relative expression of E2F3 target genes in cTEC 
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2.4.4 DC and DCS have an increasingly pro-inflammatory signature with age 
 
 Although GO term analyses did not yield significant hits for aging-associated 
DEGs in DC and DCS subsets, GSEA revealed an increasingly pro-inflammatory signature 
with age. Genes induced after LPS simulation in human monocytes were up-regulated with 
age in thymic DC and DCS (Figure 2.13A) (123). Aging is associated with increased 
inflammation (124) and inflammatory cytokines become elevated in human thymi with age 
(125). Both previously described and unreported pro-inflammatory molecules, including 
Il1a, Il1b, Cxcl2, Il-6, Il12b, Il18, and Tnf were upregulated in thymic dendritic cells at 6 
months of age (Figure 2.13B), suggesting that an increasingly inflammatory environment 






Figure 2.13 Increased expression of pro-inflammatory genes in aging DC and DCS 
subsets. 
(A) GSEA analysis reveals a positive correlation between LPS stimulated genes and 
genes up-regulated with age in DC and DCS (NOM p-value=0.054, NES=1.51 for DC, 
NOM p-value=0.025, NES=1.6 for DCS). (B) The heat map displays the relative 
expression of all LPS induced genes that are positively correlated with aging in DC and 
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2.4.5 Diminished niche activity, declining TEC homeostasis, and a decrease in 
growth factors are associated with early thymic involution 
We analyzed pathways and genes previously implicated in late thymic involution 
to determine if their expression was altered in stromal subsets during the early stages of 
thymic degeneration. Dll4, Il7, and KitL, which are all required for a functional thymocyte 
progenitor niche, were expressed at the highest levels by cTECs. Only Dll4 expression 
diminished over 1 to 6 months (Figure 2.14A), suggesting a decline in Notch signaling 
contributes to early thymic involution. 
Several studies have implicated decreased Foxn1 expression as a major contributor 
to thymic involution (88, 96). Foxn1 was not identified as an aging-associated DEG 
because it did not meet the <0.01 p-value criterion. However, Foxn1 expression declined 
~2 fold in both cTEC and mTEClo subsets from 1 to 6 months of age (Figure 2.14B), 
consistent with previous findings at later stages of involution (85, 88). Two recent studies 
associated late thymic involution with altered expression of Wnt pathway genes (88, 92). 
Consistent with these studies, Wnt3a and Wnt4 were downregulated in early thymic 
involution, specifically in cTEC and mTEClo cells, while Wnt10a was upregulated in the 
mTEClo subset (Figure 2.14B). Consistent with Griffith et al., Wnt5b was slightly 
upregulated by 6 months; however, this increase occurred in fibroblasts. Taken together, 
some Wnt family members and Foxn1 are deregulated early in thymic involution, 
suggesting that TEC homeostasis is impaired, consistent with decreased TEC proliferation 
and E2F3 activity described above. 
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Inflammatory cytokines are upregulated in aging human thyme (125). Similiarly, 
Lif, Il6, and Osm were upregulated in murine thymic dendritic cell subsets over 1 to 6 
months (Figure 2.15A). Furthermore, Tnf, Il1a and Il1b were upregulated by DCS. 
Interestingly, the activating receptor Il1r1 was expressed by all TECs and fibroblasts, while 
the IL1 antagonists Il1rn and Il1r2 were expressed by mTECs, suggesting IL1 likely 
impinges preferentially on cTECs and fibroblasts. We also note a trend of increased Csf1 
expression by mTEClo over 1 to 6 months, which can drive dendritic cell differentiation 
(126).  
Sex steroids and growth factors can modulate thymic size (81). For example, 
castration transiently increases thymic size and output (91, 92). Androgen receptor, Ar is 
expressed predominantly on cTEC, but is not upregulated over 1 to 6 months (Figure 
2.15B). Administration of growth hormone and KGF also induce growth of involuted 
thymi (81). Expression of the growth hormone receptor Ghr was not altered over 1 to 6 
months in TECs (Figure 2.15B); however, it was decreased with age in fibroblasts, which 
expressed the highest levels of Ghr at 1 month. The expression of Fgfr2/Kgfr on cTEC and 
mTEClo cells did not decline over 1 to 6 months. However, expression of the ligand, 
Fgf7/Kgf diminished in both mTEChi cells and fibroblasts between 3 to 6 months (Figure 
2.15B). Taken together, our data suggest that reduced growth factor signaling during early 










Figure 2.14 Thymocyte niche factors and TEC homeostasis implicated in late thymic 
involution are deregulated in thymic stroma by 3 to 6 months 
Graphs display the relative expression levels of genes involved in (A) thymocyte 
progenitor niche activity, and (B) TEC homeostasis in the thymus. For all graphs, 
expression values are normalized to the subset expressing the highest level of each gene at 
1 month of age. The color graphs on the left display expression levels of genes of interest 
for each stromal subset at 1 month. The grayscale graphs on the right display expression 
levels of the same genes from 1 to 6 months for the indicated thymic stromal subsets. 






































































































Figure 2.15 Inflammation and hormone implicated in late thymic involution are 
deregulated in thymic stroma by 3 to 6 months 
Graphs display the relative expression levels of genes involved in (A) 
inflammation, and (B) sex steroid and growth hormone signaling in the thymus. For all 
graphs, expression values are normalized to the subset expressing the highest level of each 
gene at 1 month of age. The color graphs on the left display expression levels of genes of 
interest for each stromal subset at 1 month. The grayscale graphs on the right display 
expression levels of the same genes from 1 to 6 months for the indicated thymic stromal 








































































































2.4.6 A searchable web-based platform containing thymocyte and thymic stromal 
cell gene expression data 
 
To make our thymic stromal expression data easily accessible, we have uploaded 
the datasets to the web-based platform Gene Expression Commons (GExC), where we have 
generated an online model containing both thymic stromal microarray datasets and our 
previously published thymocyte datasets (106) (https://gexc.stanford.edu/model/475). 
Users can readily query expression of genes of interest (GOI) in thymocyte or thymic 
stromal subsets (Figure 2.16A). One of the most powerful features of this platform is that 
data are normalized against a common reference of ~12,000 diverse datasets; thus, gene 
expression values can be compared against the full dynamic range of expression values for 
each probe set (106). In addition to normalized signal intensity values, “gene expression 
activity values” are provided on GExC. After using a step function to determine the 
threshold of expression for each probe set, each intensity value above and below this cutoff 
was assigned a percentile rank, reflecting the distribution of values in the common 
reference, as seen in the histograms (Figure 2.16C-D). For example, if a 30% “gene 
expression activity” value is obtained, the subset queried expresses the gene at a level 
above the first 30% of the common reference datasets over the threshold, and below the 
remaining 70%. This enables users to determine how robustly a gene is expressed relative 
to the range of expression values across diverse tissues. A second key advantage is the 
ability to readily search for expression patterns of interest, such as genes uniquely 
expressed in cTEC (Figure 2.16B). Finally, the combination of thymic stromal data with 
our previously published thymocyte data (106), will enable users to search for partner 
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genes, such as receptors and ligands, that may contribute to thymocyte: stromal cell 
crosstalk. For example, the chemokine receptor Cxcr4 is expressed in cortical double 
negative (DN) and double positive (DP) thymocytes, as well as in thymic dendritic cells 
and fibroblasts, while its ligand Cxcl12 is highly expressed by cTECs (Figure 2.16C). This 
in silico model should greatly facilitate discovery of molecular mediators of thymocyte: 
stromal cell crosstalk, thymic stromal function, and altered gene expression in stromal cells 











Figure 2.16 GExC platform for exploring expression data from thymocytes and thymic 
stromal subsets.   
(A) The “Complete thymocyte: stromal interaction” model in GExC 
(https://gexc.stanford.edu/model/475). Eleven thymocyte subsets (at 1 month of age) and 
six thymic stromal subsets (at 1, 3, or 6 months of age) are represented as boxes, with 
colors representing the average expression level of data from biological replicates (n=3 
and n=2 replicates for thymocyte and stromal subsets, respectively). (B) In this example 
of the pattern search feature on GExC, high expression in cTECs relative to all other 
subsets will be queried. (C) The database is useful for querying ligand-receptor pairs 
involved in thymocyte: stromal cell crosstalk. For example, the chemokine Cxcr4 is 
expressed by cortical thymocytes, as well as dendritic cells, while the ligand Cxcl12, is 
expressed at high levels by cTEC. The dynamic range of each probeset is displayed as a 
histogram, enabling users to ascertain expression levels relative to the range of values in 





We present global gene expression data from six thymic stromal subsets over the 
course of early thymic involution (1, 3, and 6 months of age) on a web-based platform as 
a resource for the scientific community (https://gexc.stanford.edu/model/475). 
Unsupervised clustering reveals the datasets are highly consistent (Figure 2.2), and qRT-
PCR analyses on independently sorted samples validate the microarray expression data 
(Figure 2.3A). Nonetheless, there are several potential caveats to consider when querying 
the GExC database. First, thymic fibroblasts were sorted based on the absence of markers 
on hematopoietic cells, erythrocytes and endothelial cells, enhancing the possibility for 
contamination with other cell types. Nevertheless, strong transcription of adhesion 
molecules, ECM components, and platelet-derived growth factor receptors reveal this 
population is highly enriched in mesenchymal cells. Second, the sorted populations may 
be heterogeneous. The transcriptional profile of rare TEC progenitors included in cTEC or 
mTEClo subsets would be entangled in the larger population. As additional TEC subsets 
are identified, it will be important to compare their transcriptional profiles against the 
parental TEC population. Third, when viewing gene expression activity values in GExC, 
it is important to remember that gene expression activity values are scaled relative to the 
large common reference. This can cause a visual flattening of expression changes; for 
example, because Foxn1 is uniquely expressed in TECs, the ~2 fold decrease in expression 
over 1 to 6 months in cTEC and mTEClo cells (Figure 2.14B) is not as visually striking as 
the high expression in TECs relative to all other cell types. Also, gene expression activity 
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values can be saturated (seen as 100%), as in the case of Psmb11/b5t in cTEC, obscuring 
the 20-50-fold increase in expression relative to other TEC subsets. In both cases above, it 
is important to compare the normalized signal intensity values, provided for download or 
on the “list” tab of GExC, to assess relative changes in expression with age or between 
subsets, respectively. 
Surprisingly, our analyses revealed a significant association of mTEChi DEGs with 
the ‘defense response’ GO term. mTEChi is the most distal thymic stromal population by 
PCA analysis (Figure 2.2B), and its distinct transcriptional profile could result from 
expression of diverse TRAs. TRA expression is largely driven by Aire (44), and 38% of 
genes uniquely expressed in mTEChi overlapped with Aire-regulated genes (Figure 2.5A). 
However, not all Aire-regulated genes are TRAs (48), and the remaining 62% of mTEChi 
DEGs may serve a function beyond elimination of autoreactive thymocytes. The GO term 
category ‘defense response’, includes genes such as defensins and cytokines (Figure 2.5C), 
which are critical for early innate immune responses against pathogens. Some of these 
genes (Defb8, Defb3) are expressed at high levels in mTEChi relative to canonical TRAs 
(Crp, Gad67) (not shown), which tend to be expressed at low levels (43, 52). Therefore, 
we speculate that these ‘defense response’ genes may serve a functional role in mTEChi 
biology, perhaps to protect the thymus against infection. 
Thymic involution results in diminished T cell output, leading to decreased immune 
function with age (81, 96). Both CD4+ and CD8+ T cells generated in aged mice have 
impaired effector functions (5, 89). These deficiencies can be attributed in part to the 
impact of an aged thymic environment, as fully functional T cells were generated when 
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bone marrow precursors from aged mice were transferred into young, but not old recipients 
(90). Therefore, it is important to understand the cellular and molecular drivers of thymic 
involution, with the ultimate goal of restoring functional T cells to aged individuals or 
patients following cytoablative therapies or infections. 
Unbiased analyses of aging-associated transcriptional changes during early thymic 
involution revealed that cell cycle related genes and E2F3 transcriptional targets were 
significantly down-regulated in the mTEClo and cTEC subsets (Figure 2.11-2.12). This is 
consistent with the reduced proportion and number of cycling TECs with age (82), and the 
finding that overexpression of cyclinD1 or inactivation of Rb family members prevents 
thymic involution (94, 95). Our data add the novel perspective that E2F3 target genes, 
many of which are required for cell cycle progression, are down-regulated in both cTEC 
and mTEClo subsets by 6 months of age, suggesting that diminished cell cycle progression 
in TECs is an early hallmark of thymic involution. A recent study revealed that Foxn1 is 
an E2F3 target gene (94). Thus, diminished E2F3 activity could directly reduce Foxn1 
levels, consistent with the reduction in Foxn1 expression in TECs by 6 months of age 
(Figure 2.14B). Foxn1 is a critical regulator of thymic involution, as diminished Foxn1 
expression results in premature involution (86), while enforced re-expression in aged TECs 
increases TEC cellularity and function and thymocyte output (88). However, maintenance 
of Foxn1 expression in TECs was insufficient to prevent thymic involution (87), suggesting 
modulation of other E2F3 targets and pathways contribute to involution. Foxn1 has also 
been implicated in regulating genes associated with cell cycle, such as Ccnd1 (88); thus, 
there is likely a complex feedback mechanism driving both diminished cell cycle 
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progression and Foxn1 levels. Expression of e2f3 itself is not significantly altered in cTEC 
and mTEClo from 1 to 6 months (not shown), suggesting that E2F3 activity is modulated 
over the course of thymic involution. Identifying initial drivers of reduced E2F3 function 
will likely reveal critical regulators of thymic involution.  
Diminished expression of Wnt pathway genes has also been implicated in age-
associated TEC degeneration (88, 92). In agreement with these studies, we find that Wnt3a 
is diminished ~1.5 fold in cTEC and mTEClo at 6 months, while Wnt4 is decreased ~2 fold 
in cTEC (Figure 2.14B). As Wnt4 can induce Foxn1 expression (127) and Wnt3a is 
implicated in epithelial proliferation (128), diminished expression could contribute to 
impaired TEC homeostasis. Furthermore, the subtle increase in expression of Wnt5b by 
fibroblasts, which may drive adipogenesis (129), suggests thymic mesenchymal cells could 
promote the age-associated increase in adipose tissue early in involution. We did not find 
evidence for altered expression of other Wnt family members (not shown), suggesting that 
deregulation of some Wnts (88, 92) may occur late in the involution process. 
Reduced potency of the thymocyte progenitor niche may also impair thymopoiesis 
during involution. IL-7, Dll4, and Kitl, expressed by TECs, are all critical for promoting 
survival and differentiation of early thymocyte progenitors (100). Of these niche factors, 
only expression of Dll4 was diminished in cTECs by 6 months of age (Figure 2.14A), 
suggesting the thymic niche may have a reduced capacity to stimulate Notch signaling, 
thus impairing thymopoiesis in early involution. IL-7 levels are reduced in late thymic 
involution (85); however, the lack of transcriptional downregulation over 6 months 
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suggests that diminished IL-7 may be due to reduced cTEC numbers in the involuted 
thymus. 
Signaling via sex steroids and growth hormones has also been implicated in thymic 
involution (81). Our data do not reveal altered expression levels of Ar in TECs over 1 to 6 
months (Figure 2.15B) or in estrogen or progesterone receptors (not shown). Taken 
together with the findings that sex steroid ablation induces only transient and partial 
regeneration of the thymus (92) and that sex steroids diminish with age, while the thymus 
continues to involute (96), our data do not suggest that sex steroids play a significant role 
in early thymic involution. However, it is possible that altered sensitivity to signaling by 
sex steroid hormones in aging TECs could promote involution. Our data suggest that 
altered growth factor signaling could contribute to early thymic involution because Ghr 
and Fgf7/Kgf expression was decreased in fibroblasts by 6 months (Figure 2.15B). Because 
both TECs and fibroblasts express Ghr, thymic rebound induced by growth hormone (130) 
may be due to signaling in both stromal subsets. Reduced expression of Fgf7/Kgf by aging 
fibroblasts may diminish signaling through FGFR2 on cTEC and mTEClo cells, 
contributing to TEC atrophy. Consistent with this notion, treatment with KGF causes 
transient thymic regeneration (104).  
Unbiased analyses of our data revealed an increasingly proinflammatory signature 
of DC and DCS with age (Figure 2.13). A previous study demonstrated that expression of 
Osm, Lif, Scf, and Il6 increased in aged human thymi, and administration of these 
cytokines promoted thymic atrophy in mice (125). Our analyses add further insight that 
Osm, Lif and Il6 are upregulated by thymic dendritic cells early in the course of involution, 
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though we found no evidence for increased Scf, either due to species or temporal 
differences. We also identified additional genes associated with inflammation that are 
upregulated by thymic dendritic cells by 6 months of age (Figure 2.13). Il1a and Il1b are 
strikingly upregulated by thymic dendritic cells, whereas activating, but not inhibitory Il-1 
receptors are expressed on cTEC and fibroblasts (Figure 2.15A). IL-1 administration 
promotes thymic atrophy(97), and Nlrp3 deficient mice, which cannot generate active IL-
1, preferentially maintain the cTEC compartment with age (131). Taken together, these 
data suggest that IL-1 produced by thymic dendritic cells is likely a potent mediator of 
early thymic involution, signaling to both cTEC and thymic fibroblasts. Interestingly, Csf1, 
which can promote dendritic cell differentiation, is upregulated in mTEClo at 6 months 
(Figure 2.15A). Thus, a feedback loop may exist in which aging TECs promote 
differentiation of dendritic cells, whose inflammatory cytokines in turn promote TEC 
degeneration. Further elucidation of the mechanisms driving DCs to adopt a pro-
inflammatory signature and causing TECs to reduce E2F3 activity and cycling will be key 




Chapter 3:  EBI2 contributes to thymocyte central tolerance by 
promoting thymocyte medullary accumulation and rapid motility 
The contents of the chapter are modified from Sanghee Ki, Jessica N. Lancaster, 
Zicheng Hu, and Lauren I.R. Ehrlich. EBI2 contributes to thymocyte central tolerance by 
promoting thymocyte medullary accumulation and rapid motility3,4 
 
3.1 ABSTRACT 
A key function of the thymus is to avert autoimmunity by ensuring that autoreactive 
thymocytes are either deleted or disabled. Maturing thymocytes enter the thymic medulla, 
where they encounter a wide range of self-antigens presented by APCs. Those 
thymocytes that are strongly self-reactive either undergo negative selection or diversion 
into the regulatory T cell lineage. Although the majority of the proteome is expressed in 
the medulla, many self-antigens are expressed by only a minor fraction of medullary 
APCs; thus, thymocytes must efficiently enter the medulla and scan numerous APCs for 
complete self-tolerance induction. Chemokine receptors promote lymphocyte migration, 
organization within tissue microenvironments, and interactions with APCs in the thymus 
and other lymphoid organs. The chemokine receptor EBI2 governs localization of T cells, 
                                                
3 Acknowledgement: We thank Jason Cyster for provision of Ebi2-/- mice and for helpful suggestions, 
Hilary Selden for technical assistance, Ellen Richie for helpful suggestions, and the staff of the UT Austin 
animal facility for assistance with mice.  
4 Authorship contributions: SK performed most of experiments with advice from LE, and wrote the 
manuscript with LE. SK and JL performed slice deletion and 2photon imaging experiments. ZH generated 
qRT-PCR data of EBI2.  
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B cells, and dendritic cells (DCs) during immune responses in secondary lymphoid 
organs. However, the role of EBI2 in thymocyte development has not been elucidated. 
Here, we demonstrate that EBI2 is expressed by murine CD4+ single positive (CD4SP) 
thymocytes and thymic DCs. Although EBI2 deficiency did not impact thymocyte 
cellularity or subset distribution, the TCR repertoire was altered in Ebi2-/- mice. 
Furthermore, negative selection of OT-II TCR transgenic thymocytes in response to an 
endogenous antigen was impaired due to thymocyte-intrinsic EBI2 deficiency, as 
opposed to deficiency in the DC compartment. Two-photon imaging revealed that EBI2 
deficiency resulted in slower migration and impaired medullary accumulation of CD4SP 
thymocytes. These data identify a role for EBI2 in promoting efficient central tolerance.  
 
3.2 INTRODUCTION 
The thymus provides an environment that is conducive for differentiation of T cells 
that are self-MHC restricted and self-tolerant. During the early stages of T cell 
differentiation, thymocytes migrate throughout the cortex, where they commit to the T cell 
lineage and rearrange gene segments encoding TCRα and TCRβ chains. Thymocytes then 
undergo positive selection via interactions with cortical thymic epithelial cells (cTECs), 
enabling survival of only those cells expressing self-MHC restricted TCRs (30, 98). 
Following positive selection, thymocytes migrate into the medulla, where they undergo the 
final stages of maturation before emigrating to join the cohort of naïve T cells in secondary 
lymphoid organs.  
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The thymic medulla is a specialized microenvironment in which thymocyte 
tolerance against numerous self-antigens is induced. There are two major classes of 
medullary APCs responsible for self-tolerance induction, medullary TECs (mTECs) and 
DCs. mTEChi cells, a subset of mTECs that express high levels of MHC-II and CD80, have 
a unique role in self-tolerance induction because they express the chromatin modulator 
Aire. AIRE promotes low-level, stochastic expression of a large number of tissue-restricted 
antigens (TRAs), genes otherwise expressed only in a small number of differentiated 
tissues, such as the retina or pancreas (45). Interestingly, mTEChi cells collectively express 
about 90% of the proteome, representing the majority of proteins T cells will encounter 
throughout the body; however only a small percentage of mTEChi cells express any given 
TRA (50, 51, 132). DCs also play an essential role in presenting self-antigens to medullary 
thymocytes for tolerance induction. In addition to presenting peptides from their own 
proteome, DCs acquire antigens from mTEChi cells for presentation (9, 64). Furthermore, 
thymic Sirp⍺+ DCs and plasmacytoid DCs (pDC) present peptides from proteins in 
peripheral tissues or the circulation (9). Therefore, in order to screen the complete range of 
diverse but sparse TRAs in the medulla, thymocytes must efficiently enter the medulla and 
scan numerous APCs.  
Chemokine receptors influence central tolerance by promoting thymocyte 
medullary entry, motility, and interactions with APCs. After undergoing positive selection, 
CD4+CD8+ double-positive (DP) thymocytes up-regulate CCR4, which is required for their 
efficient medullary entry and interactions with DCs. Thus, CCR4 deficiency results in 
impaired central tolerance (10). Subsequently, CD4+ single positive (CD4SP) cells and 
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CD8SP cells express CCR7, which is critical for their accumulation within the medulla and 
rapid motility (74, 133). CCR7 deficiency also results in impaired central tolerance (74, 
75, 134-136). In addition to these two chemokine receptors, our analysis of expression 
profiling data from thymocytes and thymic stromal cells identified other candidate 
chemokine: chemokine receptor pairs that could promote medullary accumulation (137). 
Furthermore, Ccr4-/-Ccr7-/- SP cells are capable of entering the medulla (77), albeit 
inefficiently, but pertussis toxin completely inhibits SP medullary entry (74), indicating 
that other chemokine receptors contribute to medullary accumulation of SP cells, and thus 
central tolerance induction.  
EBI2 (Epstein-Barr virus induced molecule 2) is a chemokine receptor expressed 
by several lymphocyte subsets that promotes chemotaxis in response to 7⍺25-OHC, a lipid 
metabolite of cholesterol (138-141). EBI2 regulates the localization of B cells within 
follicles during primary immune responses (142-144). In the absence of EBI2, B cells 
localize prematurely to the center of follicles, resulting in impaired generation of 
plasmablasts and GC B cells, and reduced early antibody production  (138, 142). EBI2 
also induces localization and homeostasis of CD4+ DC in splenic bridging channels, 
enabling them to efficiently acquire and present particulate antigens during primary 
immune responses (145). In addition, EBI2 guides activated CD4+ T cells towards follicles, 
promoting differentiation of Tfh cells through interactions with specialized DCs in the 
outer T cell zone (146). Interestingly, genome-wide studies have implicated single 
nucleotide polymorphisms near the EBI2 locus in autoimmune diseases, such as Type 1 
diabetes (147), indicating that mislocalization of lymphocytes impacts autoimmune 
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susceptibility as well as pathogen-driven immune responses. The contribution of EBI2 to 
thymocyte differentiation has not been established.  
In this study, we have identified a role for EBI2 in thymocyte migration and 
negative selection. We demonstrate that EBI2 promotes chemotaxis of mature CD4SP cells 
and alters the  TCR repertoire. EBI2 contributes to negative selection of OT-II TCR 
transgenic thymocytes in response to an endogenous auto-antigen, and shifts the balance 
in favor of negative selection as opposed to Treg generation in the presence of high-affinity 
auto-antigens. The impact of EBI2 on negative selection is thymocyte-intrinsic, and not 
due to activity in the thymic DC compartment. In addition, using two-photon microscopy 
to track the migration of CD4SP thymocytes on live thymic slices, we show that EBI2 
promotes rapid motility of CD4SP cells and contributes to their medullary accumulation. 
Together, our findings provide evidence that EBI2 is required for full motility of medullary 
CD4SP thymocytes and contributes to efficient negative selection. 
3.3 EXPERIMENTAL PROCEDURES 
Mice 
C57BL/6J (CD45.2), B6.SJL-Ptprca Pepcb (CD45.1), B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-
II), C57BL/6-Tg(Ins2-TFRC/OVA)296Wehi/WehiJ (RIP-mOVA) mice were purchased 
from The Jackson Laboratory. Ebi2-/- and pCX-EGFP(148) strains were generously 
provided by Jason Cyster (UCSF) and Irving L. Weissman (Stanford University, 
Stanford, CA), respectively. CD45.1/CD45.2, CD45.1 OT-II, and Ebi2-/- OT-II strains 
were bred in-house. All strains were bred and maintained under specific pathogen–free 
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conditions at the University of Texas at Austin animal facility. Mouse maintenance and 
experimental procedures were performed with approval from the University of Texas at 
Austin’s Institutional Animal Care and Use Committee.  
 
Antibodies and flow cytometry 
All antibodies were obtained from eBioscience or Biolegend unless otherwise 
indicated: anti-CD8 (53-6.7), -CD69 (H1.2F3), -CD3 (145-2C11), -CD4(RM4-5), -CD25 
(PC61.5), -CD45.1 (A20), -CD45.2 (104), -Vα2 (B20.1), -Vβ5 (MR9-4), -CD11c 
(N418), -Ter119 (TER-119), -B220 (RA3-6B2), -Gr-1 (RB6-8C5), -CD11c (M1/70), -
NK1.1 (PK136), -cKit (2B8), -CD31 (390), -Sirp⍺	(P84), -I-A/I-E (M5/114.15.2), -CD80 
(16-10A1), -CD45 (30-F11;BD), -Ly51 (6C3), -EpCAM (G8.8), -PDCA1 (eBio917), -
Aire (5H12). Anti-Streptavidin Qdot®-605 (Life Technologies) was used as a secondary 
reagent to detect biotinylated primary antibodies. 
Antibodies used for immunofluorescent stains are listed below: anti-Pancytokeratin-
FITC (C-11; Sigma-Aldrich), -keratin5 (rabbit polyclonal antibody; Covance), -CD4-
APC (FM4-5; eBiosicence), -CD8-Alexa Fluor 488(53-6.7; eBioscience), CD11c-biotin 
(N418; BioLegend), Donkey anti-rabbit IgG DyLight 488, (Jackson ImmunoResearch 
Laboratory), Donkey anti-rabbit IgG DyLight 594 (Jackson ImmunoResearch 
Laboratory), Streptavidin Alexa 647 (Life Technologies).  
For flow cytometry, single-cell suspensions of thymocytes were obtained by manual 
dissociation and filtration through a 40-µM cell strainer (Thermo Fisher Scientific).  
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3x106~107 thymocytes were stained with fluorochrome-conjugated or biotinylated 
antibodies for 20 min in the dark at 4°C in FACS wash (FW; PBS+ 2% bovine calf serum 
[BCS]; GemCell). Biotinylated antibodies were detected with Streptavidin Qdot 605 
(Life Technologies). 1 µg/ml Propidium iodide (PI; Enzo) was added to identify dead 
cells, and the suspension was analyzed with a LSR Fortessa flow cytometer (BD). FlowJo 
ver.9.9 (Tree Star) was used for data analysis.  
 
qRT-PCR  
Single cell suspensions of thymocytes were obtained by mechanically dissociating 
C57BL/6J thymi, and thymocyte subsets were sorted as described previously (10). Single 
cell suspensions of thymic stromal cells were obtained by enzymatically dissociating 
C57BL/6J thymi with Collagenase D and Collagenase/Dispase (Roche) as previously 
described (107, 137) (see Figure 3.1 for gating strategies). Thymic stromal cells were 
immuno-stained with antibodies against MHCII, Epcam, CD45, CD80, UEA, Ly51, Ter-
119, CD11c, CD31, Sirp⍺, B220 to sort TEC and DC subsets. Gating schemes were 
applied as described previously (137). Briefly, all TECs were gated as CD45- MHCII+ 
Epcam+ cells, and then subdivided into mTEChi (UEA-1+ CD80hi MHCIIhi), mTEClo 
(UEA-1+ CD80lo MHCIIlo) and cTEC (UEA-1- MHCII+ Ly51+) subsets. DCs were first 
gated as MHCII+Epcam- CD11c+ cells, and further divided by Sirp⍺ expression. 
Thymocyte, TEC, and DC subsets were sorted to >95% purity using a FACSAria II (BD), 
and the cells were resuspended in TRIzol ( Life Technologies), from which RNA was 
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extracted according to the manufactuer’s protocol. cDNA was generated using 
SuperScript® III First-Strand Synthesis SuperMix (Life Technologies). qRT-PCR was 
performed as described previously (10).  
 
Chemotaxis assays  
For DC chemotaxis assays, thymi were enzymatically digested with Liberase, as 
previously described, with modifications (Roche)(149). Briefly, 3 sequential incubations 
in 4%Liberase+0.02%DNaseI were carried out for 12minutes at 37C, and released cells 
were collected in FW + 0.5mM EDTA after each incubation. Cells were immunostained 
with anti-CD11c-biotin (N418) for 30min on ice, followed by Streptavidin-MicroBeads 
(MACS; Miltenyi Biotec) for 20min on ice. MACS columns (25LS columns; 
Miltenyibiotec) were used to positively enrich CD11c+ cells according to manufacturer’s 
specifications. 3-7x104 DCs were aliquoted into the top chamber of a 5.0 µm pore 24 well 
chemotaxis plate, (Costar) in RPMI media (RPMI-1640 medium [Gibco] supplemented 
with 10% FBS[Hyclone]). 7⍺25-OHC (Sigma) was added to the bottom of each chamber 
at indicated concentrations, and plates were incubated at 37°C for 2 hours. Cells that had 
migrated into the bottom chamber were analyzed by flow cytometry after 
immunostaining with anti-: CD11c- eFluor®450, PDCA1-PE, Sirpα-APC, MHCII-
PE/Cy7, B220-APC/Cy7. The chemotactic index was calculated as the ratio of the 
number of cells in the bottom chamber at a given concentration of ligand versus the 
number of cells in wells without ligand. 
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For thymocyte chemotaxis assays, 3x105 thymocytes were placed in the upper well of 
a chemotaxis chamber and the indicated concentrations of 7⍺25-OHC were added in 
RPMI in the bottom wells. After 2 hours, cells in the bottom chamber were analyzed by 
flow cytometry with the following antibodies anti-: CD4-APC, CD8-eFluor®450, CD3-
PE/Cy7, CD69-Qdot® 605, CD25-Alexa® Fluor700.  
 
Immunofluorescence  
Ebi2+/+ and Ebi2-/- thymi from mice at 1 month of age were embedded in Tissue-Tek 
OCT compound (Sakura) and snap frozen. 6-9 µm cryosections were prepared on a 
Microm HM550 Cryostat (ThermoFisher) and stored at -80°C. Cryosections were fixed 
in 100% acetone at -20°C for 15min and washed 2X in PBS + 0.1% Tween 20. 
Immunostaining was carried out for 1hr at 4°C with indicated primary antibodies against 
the following: Keratin5 (rabbit polyclonal), PanCK (C11)-FITC, CD4-APC, CD8-FITC, 
and CD11c-biotin. TheTSA Signal Amplification kit was used (Perkin Elmer) to boost 
the CD11c signal. Incubation with the following secondary antibodies for 1hr at 4°C was 
used for detection: Donkey-anti-rabbit IgG DyLight 594. Images were acquired on a 
DMi8 (Leica) epifluorescent microscope, using HC PLAPO 10x/0.4DRY (NA=0.4) and 
HC PLAPO 20x/0.7 (NA=0.7) DRY objectives and LasX (Leica) software.  
 
Bone marrow chimeras 
 For mixed bone marrow chimeras, donor Ebi2+/+ CD45.1 and Ebi2-/- CD45.2 bone 
marrow (BM) cells were depleted of mature lineages by incubating for 30min on ice with 
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the following antibodies (BioXCell): CD3, CD4, CD8, Mac1, Gr-1, Ter1, NK1.1, B220, 
followed by incubation for 10min at room temperature with sheep anti-rat IgG 
Dynabeads® (Invitrogen), and magnetic depletion. Ebi2+/+ and Ebi2-/- lineage-depleted 
BM cells were mixed at 1:1 ratio, and injected i.v. into lethally irradiated (900 rad in 2 
split doses) CD45.1/45.2 congenic recipients. Thymic chimerism was assessed by flow 
cytometry 6 weeks after transplantation. For, OT-II chimeras, the same procedure was 
followed, but donor bone marrow came from Ebi2+/+ OT-II mice or from Ebi2+/+ OT-II, 
and recipients were either irradiated RIP-mOVA+ or RIP-mOVA- mice, as indicated. 
 
In vitro viability assay 
106 thymocytes from Ebi2+/+ CD45.1 and Ebi2-/- CD45.2 mice were incubated at 37°C in 
5% CO2 for 24 hours in the absence or presence of 7⍺,25-OHC at the indicated 
concentrations in 96 well plates in 200µl of complete RPMI (RPMI-1640 medium 
[Gibco] supplemented with 10% FBS [Hyclone], 1x GlutaMAX [2mM L-alanyl-L-
glutamine], 1x Penicillin [100U/ml]- Streptomycin [100µg/ml]-Glutamine [300µg/ml; 
Gibco], 1mM Sodium Pyruvate, 1x MEM NEAA, and 50µM 2-mercaptoethanol [all from 
Gibco]). After 24hrs, cells were collected and stained with anti-CD8, CD69, CD45.1, 
CD25, CD3, CD4, and AnnexinV-PE (eBiosicence), and resuspended in FW + 1 µg/ml 




Thymocytes were obtained from Ebi2+/+ and Ebi2-/- mice, and CD4SP thymocytes were 
enriched by magnetic depletion after incubation with the following purified antibodies, as 
for lineage depletion of BM: CD8, Gr-1, Ter119, B220, CD25, CD11b, and purity was 
assessed by flow cytometry as >85%. 1x106 Ebi2+/+ and Ebi2-/- CD4SP cells were stained 
with Indo-1AM (Sigma) and CMTPX red (Life Technologies), respectively, for 30min at 
37°C,	according to manufacturers’ instructions. Cells were washed and destained in 
complete RPMI for 30min at 37°C. Ebi2+/+ and Ebi2-/- stained cells were mixed at 1:1 
ratio, and resuspended in complete RPMI. 3-4 week old pCX-EGFP thymi were 
embedded in low-melt agarose (Lonza) and vibratome sectioned, with a VT1000S 
Vibratome (Leica), as previously described (74). After incubation for 1-2 h at 37°C 5% 
CO2, images of thymic slices were acquired every 15 s, through a depth of 40 µm, at 5-
µm intervals using an Ultima IV microscope with a 20x objective, NA 1.0, and 
PraireView software (Prairie). The sample was illuminated with two MaiTai lasers one 
tuned to 740 nm, and the other to 900 nm, to excite Indo and EGFP/CMTPX, 
respectively. Emitted light was passed through 480/40, 535/50, and 607/45 bandpass 
filters (Chroma) for detection of Indo1, EGFP, and CMTPX fluorescence, respectively. 
Cell tracking and analysis was carried out using Imaris v.8 (Bitplane): average cellular 
velocity was calculated as path length divided by time; straightness was calculated as 




Thymocytes were obtained from CD45.1 Ebi2+/+ OT-II, CD45.2 Ebi2-/- OT-II and 
CD45.1 (loading control) mice and mixed at a 1:1:1 ratio. Mixed cells were stained with 
CMF2HC cell tracker blue (Life Technologies), according to the manufacturer’s protocol. 
3x106 cells were incubated on top of each Ebi2+/+ or Ebi2-/- thymic slice, prepared as 
described fore two-photon microscopy. Slices were incubated for 24hours at 37°C, 5% 
CO2 in complete RPMI on 0.4-µm cell culture inserts (Millipore) in 35mm dishes with 
the indicated concentrations of Ovalbumin323-339 peptide (OVAp). Slices were then 
manually dissociated, and cells were immunostained for flow cytometric analysis.  
To compare indicated cell populations, we first normalized cell numbers to the 
number of CD45.1 cells of the comparable population that entered each slice to account 
for differences in slice entry. These numbers were then normalized to either the number 
of cells of the same population input onto the slice or in slices without OVAp, as 
indicated. The percentage of responding cells= (100- the percentage of surviving cells) + 
(the percentage of CD4SP cells upregulating CD25). The percentage of surviving cells 
was calculated as the number of CD4SP cells (normalized for slice entry) at a given 
concentration of OVAp divided by the number of CD4SP cells in the 0nM OVA slices, 
times 100. The percentage of CD4SP cells upregulating CD25 for a given concentration 
of OVAp was calculated as the number of CD4+CD25+ cells (normalized for slice entry) 
divided by the number of these cells in slices without OVAp, times 100. Propagate R 
package v 1.0-4 was used to calculate standard variations. 
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For some slice deletion experiments, WT OT-II and CD45.1 thymocytes were 
mixed at 1:1 ratio, stained with CMF2HC cell tracker blue (Life Technologies), and 
incubated on either Ebi2+/+ and Ebi2-/- thymic slices, prior to analysis as above.  
 
Statistical analyses 
Cortical and medullary regions were quantified from immunofluorescent stains 
using the K-means clustering plug-in in FIJI (150). The number of clusters were set to 
three to distinguish background, cortex, and medulla, followed by analysis of particles in 
each cluster. Two-way ANOVA was used to assess significance of differences in 
thymocyte subset cellularity due to the Ebi2 genotype and/or the RIP-mOVA transgene. 
Paired t-tests were used to compare medullary/cortical densities of Ebi2+/+ and Ebi2-/- 
CD4SP cells from 2-photon imaging data because cells of both genotypes were analyzed 
together in each dataset. Unpaired T-tests were used in remaining analyses. All statistical 
analysis was done using Prism6 (Graphpad). P-values are marked with asterisks (*); * p-
value<0.05, ** p-value<0.01, *** p-value<0.001, **** p-value<0.0001  
 
3.4 RESULTS 
3.4.1 Expression and function of EBI2, implicate a contribution to CD4SP 
thymocyte differentiation 
To identify candidate GPCR/ ligand pairs that could affect migration of post-positive 
selection thymocytes in the medulla, we analyzed our transcriptional profiling database of 
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thymocyte and thymic stromal cell subsets (137). EBI2 emerged as a candidate because it 
was expressed after positive selection in DP and CD4 SP thymocytes. Additionally, 
Ch25h, which encodes an enzyme required for generation of the EBI2 ligand 7⍺25-OHC 
(144), was highly expressed by mTEClo cells (data not shown). qRT-PCR analysis of 
Ebi2 and Ch25h in FACS sorted thymocyte and thymic stromal subsets (Figure 3.1), 







Figure 3.1 Gating schemes for thymocytes and expression patterns of Ebi2 and, Ch25h.  
(A) DN population (B) CD4SP and CD8SP gating schemes for FACS sorted thymocyte 
(C) Ebi2 and (D) Ch25h mRNA expression levels were quantified by qRT-PCR in FACS 
sorted thymocyte and thymic stromal subsets. Expression was normalized to (C) DP 
CD69- levels and (D) thymocyte levels. Data are representative of 2 independent 







































































































































































































Next, we analyzed GFP expression in thymocytes from Ebi2+/+, EBI2+/GFP (Ebi2+/-) 
and EBI2GFP/GFP (Ebi2-/-) mice, in which the Ebi2 open reading frame has been replaced 
with EGFP (143). GFP was first detectable at the immature CD4+ CD69+ stage, with the 
highest expression in mature CD4+ CD69- cells, indicating that EBI2 protein is not 
produced until positively selected thymocytes are committed to the CD4SP lineage. 
CD4+CD25+ thymocytes, which include Treg precursors (Tregp) and Treg cells, also 
expressed GFP (Figure 3.2). In addition, CD4+ T cells in the spleen and lymph nodes 






Figure 3.2 Expression patterns of Ebi2 and, Ch25h, implicates Ebi2 in post-positive 
selection CD4SP thymocytes.  
(A) Representative flow cytometry plots showing GFP levels expressed by the indicated 
thymocyte subsets, and by lymph node and splenic CD4+ T cells (LN CD4+ and Spl 
CD4+, respectively) from Ebi2-GFP knock-in mice of the indicated genotypes. (B) 
Quantification of the Mean Fluorescence Intensity (MFI) of GFP (left graph) and the 
percent of GFP+ cells (right graph) for the indicated thymocyte subsets from Ebi2-GFP 
knock-in mice of the indicated genotypes, from data as in C. (Ebi2+/+ n=9, Ebi2+/- n=5, 









































































































































































































Because EBI2 signaling in response to 7⍺,25-OHC induces chemotaxis of B cells and 
CD4+ T cells (139), we tested whether EBI2 promoted chemotaxis of CD4SP 
thymocytes. Indeed, 7⍺,25-OHC induced chemotaxis of CD4SP thymocytes in an Ebi2-
dependent manner in vitro (Figure 3.3A). Notably, Ebi2+/- thymocytes did not undergo 
efficient chemotaxis in response to 7⍺,25-OHC, indicating a haploinsufficiency 
phenotype. EBI2 also promoted chemotaxis of CD4+CD25+ Treg and Tregp in response 
to 7⍺,25-OHC (Figure 3.3B). Consistent with the GFP expression data (Figure 3.3B), DP 
CD69+cells did not undergo chemotaxis, and mature CD69- CD4SP cells were more 
responsive than immature CD4SP cells, suggesting increasing expression of functional 
EBI2 protein during CD4SP maturation (Figure 3.3B). These data demonstrate that EBI2 
induces chemotaxis of post-positive selection CD4SP thymocytes, while the enzyme 
producing the EBI2 ligand 7⍺,25-OHC is made by mTECs, suggesting that EBI2 











Figure 3.3 Chemotactic activity implicate Ebi2 in migration of post-positive selection 
CD4SP thymocytes..  
(A) Quantification of the chemotactic index of CD4SP cells of the indicated genotypes 
migrating in response to the indicated concentrations of 7⍺,25-OHC. (B) Chemotactic 
index of Ebi2+/+ and Ebi2-/- thymocyte subsets responding to 50nM of 7⍺,25-OHC. Data 
in E and F are representative of 5 independent experiments, with triplicates per 
experiment.  All graphs depict means±SEM
  








































































3.4.2 Normal thymocyte cellularity and subset composition in EBI2-deficient mice 
and competitive bone marrow chimeras 
To determine whether EBI2 was required for thymocyte differentiation, we analyzed 
thymocyte subsets from Ebi2-/- mice by flow cytometry. We did not detect significant 
differences in thymocyte cellularity or subset distribution in Ebi2-/- versus Ebi2+/+ thymi 
from mice 4-6 weeks of age (Figure 3.4A, 3.4B). Because signals from post-positive 
selection thymocytes that migrate efficiently into the medulla are required for proper 
differentiation of the mTEC compartment (73, 100), we determined whether cortical-
medullary architecture was perturbed in Ebi2-/- mice. Quantification of cortical and 
medullary regions from cryosections immunostained to identify cTEC and mTEC did not 
show evidence of disrupted thymic architecture (Figure 3.4C, 3.4D). Furthermore, 
immunostaining did not reveal disruption of the cortical localization of DP cells or 
medullary localization of CD4SP or CD8SP cells (Figure 3.4E). Thus, EBI2 is not 
required for entry of SP cells into the medulla or thymic organization.
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Figure 3.4 Thymocyte cellularity and subset composition is normal in EBI2-deficient 
mice  
(A-B) Quantification of total thymocyte cellularity (A) and frequency of thymocyte 
subsets (B) in Ebi2+/+ and Ebi2-/- mice (n=8 for each genotype). (C) Representative 
Ebi2+/+ and Ebi2-/- thymic cryosections immunostained for Keratin5 (red), marking 
medullary regions, and Pan-cytokeratin (Pan-cK; green), marking cortical regions. 
Representative of 3 thymi each. Scale bar=1mm. (D) The percentage of cortical and 
medullary epithelium in Ebi2+/+ and Ebi2-/- thymi, as determined by k-mean clustering 
analysis of images as in C (n=3 for each genotype). (E) Representative images of Ebi2+/+ 
and Ebi2-/- thymic cryosections immunostained to detect CD4 (red) and CD8 (green). The 
white dashed line demarcates medullary (M) and cortical (C) (scale bar=100µm) (n=3). 





















































































































To determine whether a defect in thymocyte differentiation would be revealed if Ebi2-
/- thymocytes were placed in a competitive setting with wild-type thymocytes, we 
analyzed mixed bone marrow chimeras. Bone marrow cells from congenically marked 
Ebi2+/+ (CD45.1) and Ebi2-/- (CD45.2) mice were lineage depleted, mixed at a 1:1 ratio, 
and injected intravenously into lethally irradiated congenic (CD45.1/CD45.2) recipient 
mice (Figure 3.5A). Ebi2-/- cells did not contribute differentially to thymocyte subsets 
relative to Ebi2+/+ cells (Figure 3.5B). Thus, EBI2-deficient bone marrow cells have a 
comparable capacity to reconstitute the thymus and undergo T cell development under 








Figure 3.5 Thymocyte subset composition is normal in competitive bone marrow 
chimeras.   
(A) Experimental schematic of competitive bone marrow chimeras and representative flow 
cytometric plots used for analysis. (B) Quantification of the ratio of CD45.2 to CD45.1 
positive cells within thymocyte subsets in the indicated bone marrow chimera recipients. 
Ratios are normalized to the pre-positive selection DP CD69- subset (Ebi2+/+ n=10, Ebi2-/- 
n=12). All graphs depict means±SEM 
  









































































































3.4.3 EBI2 deficiency results in impaired negative selection and enhanced Treg 
generation of OT-II CD4SP cells in response to self- antigens in vivo 
If EBI2 were partially reduncant with other chemokine receptors that promote 
efficient medullary entry and/or scanning of thymic APCs, then Ebi2-/- thymocytes might 
not display overt perturbations in thymocyte differentiation, but might still have subtle 
defects in negative selection. To address this possibility, we first analyzed negative 
selection of monoclonal OT-II TCR CD4SP cells. We and others previously found that 
the OT-II TCR induces weak negative selection to an endogenous auto-antigen in 
C57BL/6 mice, and strong negative selection to a high affinity cognate antigen, allowing 
us to query two different levels of self-recognition (10, 64). The Vα2+ Vβ5+ OT-II TCR 
recognizes OVAp in the context of I-Ab (151). RIP-mOVA transgenic mice express a 
transmembrane form of Ovalbumin under control of the rat insulin promoter, such that 
mTECs express OVA in an AIRE-dependent fashion (152). In RIP-mOVA+ mice, OT-II 
thymocytes undergo negative selection due to encounter of their cognate antigen in the 
medulla (64).  
We transplanted Ebi2-/- versus Ebi2+/+ OT-II TCR transgenic bone marrow into 
lethally irradiated RIP-mOVA– or RIP-mOVA+ mice, and thymic chimerism was 
analyzed after 6 weeks (Figure 3.6A). Flow cytometric analysis of recipient thymi 
revealed no differences in cellularity of post-positive selection DP CD69+ OT-II cells 
(Figure 3.6B), as expected since EBI2 does not show activity in thymocytes until the 
CD4SP stage (Figure 3.2C). Ebi2+/+ OT-II CD4SP cells underwent negative selection, as 
expected, in RIP-mOVA+ recipients. Ebi2-/- OT-II CD4SP cells also underwent efficient 
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negative selection in response to the RIP-mOVA transgene. However, a striking increase 
in cellularity of Ebi2-/- versus Ebi2+/+ OT-II CD4SP thymocytes was observed in RIP-
mOVA- recipients (Figure 3.6B). These data indicate that EBI2 is not required for 
negative selection of CD4SP cells in response to the high-affinity OVA antigen, but is 
required for negative selection in response to a weakly deleting endogenous C57BL/6J 
self-antigen. Two-way ANOVA analysis confirmed that the RIP-mOVA transgene 
resulted in significant deletion of CD4SP OT-II cells, while Ebi2 deficiency resulted in a 
significant increase in the number of CD4SP OT-II cells (Figure 3.6B). Furthermore, 
Ebi2-/- thymocytes generated more CD4+CD25+ Treg and Tregp cells (Figure 3.6B). 
Together, these results indicate that EBI2 promotes negative selection of CD4SP 




Figure 3.6 EBI2 is required for negative selection of OT-II thymocytes responding to an 
endogenous antigen, and restrains Treg generation 
(A) Schematic of bone marrow chimeras generated by transplantation of Ebi2+/+ or Ebi2-
/- OT-II bone marrow into lethally irradiated RIP-mOVA- or RIP-mOVA+ recipients. 
Thymic chimerism was analyzed 6 weeks after transplantation, and representative flow 
cytometric plots are shown. (B) Quantification of thymocyte subsets in the indicated 
chimeras. (n=10 Ebi2+/+ OT-II-> RIP-mOVA-; n=8 Ebi2+/+ OT-II-> RIP-mOVA+; n=15 
Ebi2-/- OT-II-> RIP-mOVA-; n=13 Ebi2-/- OT-II-> RIP-mOVA-). The table shows the 
results of the two-way ANOVA to analyze significance of differences in cellularity of 
each subset due to the presence of OVA, genotype of Ebi2, or interaction of these factors. 





















Ebi2-/- OT-II -> RIP-mOVA-






































































We considered alternate mechanisms by which EBI2 deficiency could result in 
increased CD4SP OT-II thymocytes in wild-type mice. First, EBI2 signaling could inhibit 
proliferation of CD4SP OT-II cells. However, EBI2 deficiency did not result in an 
increase in the frequency of proliferating CD4SP OT-II thymocytes in any of the above 
chimeras (Figure 3.7A). Alternatively, EBI2 deficiency could enhance survival of CD4SP 
thymocytes in an antigen-independent manner, resulting in an accumulation of CD4SP 
cells. To test this possibility, we incubated Ebi2-/- versus Ebi2+/+ thymocytes in the 
presence or absence of 7⍺,25-OHC overnight, and quantified the resultant viability of 
CD4SP thymocyte subsets. EBI2 deficiency did not confer increased survival on CD4SP 
thymocyte subsets (Figure 3.7B). The increase in CD4SP cells could also be due to 
impaired thymocyte egress, but this is unlikely because the proportion of CD4+ CD69- 
cells does not increase in Ebi2-/- thymi, as would be expected if mature CD4SP cells were 
retained (Figure 3.4B) Thus, we conclude that the increase in CD4SP cellularity in wild-
type recipients transplanted with Ebi2-/- OT-II bone marrow is not due to EBI2-mediated 
changes in proliferation or antigen-independent apoptosis of CD4SP thymocytes, and is 












Figure 3.7 Proliferation and survivability is normal in EBI2-deficient CD4SP. 
(A) The percentage of each thymocyte subset in the chimeras generated in Figure3.6 that 
are in cell cycle, as determined by flow cytometric analysis of DNA content. (B) Ebi2-/- 
and Ebi2+/+ thymocytes were incubated for 24 hours in vitro in the presence or absence of 
7⍺,25-OHC. The percentage of viable cells (AnnexinV-PI-) was quantified by flow 




































































Ebi2-/- OT-II -> RIP-mOVA-
Ebi2-/- OT-II -> RIP-mOVA+
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3.4.4 EBI2 deficiency results in an altered TCR repertoire 
If negative selection were truly impaired by EBI2 deficiency, then the TCR 
repertoire of CD4SP cells should be altered in Ebi2-/- mice. To test this, we analyzed 
TCRVβ gene usage in thymocytes subsets of Ebi2+/+, Ebi2+/-, and Ebi2-/- mice. We noticed 
a consistent trend of increased TCR Vβ5+ usage in CD4SP and CD4+CD25+populations 
in Ebi2-/- mice (p-value <0.05 by t-test analysis); however, the difference wasn’t 
significant after multiple comparisons corrections (Figure 3.8A). Given that Vβ5 is used 
by the OT-II TCR, which underwent impaired negative selection to a weak self-antigen, 
we more rigorously evaluated whether EBI2 deficiency altered Vβ5 usage in CD4SP 
thymocytes. Evaluation of additional Ebi2+/+ and Ebi2-/- thymocytes revealed that Vβ5 
usage increased slightly, but significantly, in Ebi2-/- CD4SP cells (Figure 3.8B). Thus, 
EBI2 deficiency subtly alters the TCR repertoire of CD4SP cells. Previous studies 
suggest that an endogenous super-antigen deletes Vβ5+ CD4SP cells on the C57BL/6J 
background (151). Therefore, EBI2 deficiency in CD4SP cells may impair negative 
selection against endogenous super-antigens, in keeping with the increased cellularity of 










Figure 3.8 EBI2 deficiency alters the TCR repertoire of CD4SP thymocytes. 
(A) Thymocytes of the indicated subsets and Ebi2 genotypes were analyzed by flow 
cytometry to determine the frequency of CD4SP cells that expressed different TCRVβ 
segments. Using a t-Test, the p-value for Vβ5 was <0.05, but significance was lost after 
Holm-Sidak multiple comparison correction. (Ebi2+/+ n=6, Ebi2+/- n=9, Ebi2-/- n=12).  
(B) The frequency of Ebi2+/+ and Ebi2-/- CD4SP cells that express TCR Vβ5 was 



















































































































3.4.5 Impaired negative selection and enhanced Treg generation of Ebi2-/- OT-II 
CD4SP cells in response to self- antigens on wild-type thymic slices 
Our data indicate that EBI2 deficiency impairs negative selection of CD4SP cells 
responding to a weak self-antigen, while promoting differentiation of CD4+CD25+ Tregp 
and Treg cells, even in the presence of a high affinity self-antigen (Figure 3.6B). To 
determine if EBI2 deficiency results in comparable phenotypes under conditions where 
Ebi2+/+ and Ebi2-/- OT-II thymocytes compete for negatively selecting ligands in a wild-
type thymic environment, we analyzed negative selection and Treg generation in wild-
type live thymic slices (74, 153). An equivalent number of CD45.1 Ebi2+/+ OT-II 
thymocytes, CD45.2 Ebi2-/- OT-II thymocytes, and CD45.1 thymocytes (which served as 
a slice loading control) were mixed together, labeled with a blue cell-tracker dye, and 
incubated on live thymic slices in the presence of OVAp, at concentrations ranging from 
0nM to 10uM. After 24 hours, thymocyte subsets derived from each OT-II population 
were analyzed by flow cytometry to assess whether negative selection and/or 
upregulation of CD25 had occurred (Figure 3.9A).  
Ebi2+/+ OT-II CD4SP CD25- cellularity diminished following incubation on slices 
for 24 hours in the absence of OVAp, indicating that negative selection of OT-II 
thymocytes to an endogenous self-antigen can be detected on thymic slices. Notably, 
Ebi2-/- OT-II CD4SP thymocytes were not deleted in response to the endogenous self-
antigen, resulting in a significant increase in their cellularity relative to EBI2 sufficient 
OT-II CD4SP cells (Figure 3.9B, left panel). Both Ebi2+/+ OT-II and Ebi2-/- OT-II 
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CD4+CD25- cells diminished in number, as they underwent negative selection in response 
to increasing concentrations of OVAp. In fact, when OT-II CD4+CD25- cellularity was 
normalized to slices without OVAp, such that relative deletion in response to increasing 
OVAp could be directly compared, Ebi2-/- OT-II CD4+CD25- cells underwent deletion as 
efficiently as Ebi2+/+ OT-II cells (Figure 3.9B, middle panel). This result is consistent 
with efficient negative selection of Ebi2-/- OT-II CD4+CD25- cells in RIP-mOVA bone 
marrow chimeras (Figure 3.6B), and further indicates that EBI2 is not required for 
negative selection to a high-avidity antigen, but only to a weakly deleting self-antigen.  
 In the presence of OVAp, Ebi2-/- CD4SP OT-II thymocytes generated 
significantly more CD4+CD25+ Tregp and Treg than Ebi2+/+ CD4 OT-II cells (Figure 
3.9B, right panel). This suggests that EBI2 modulates the decision to undergo negative 
selection versus Treg generation in the presence of high-affinity antigens. To further 
evaluate this possibility, we quantified the CD4SP cells that underwent deletion plus 
those that upregulated CD25, to evaluate the percentage of CD4SP that responded to each 
concentration of OVAp. EBI2 deficiency did not alter the frequency of CD4SP cells that 
responded to OVAp at any concentration (Figure 3.9C, left panel). We next calculated the 
percentage of CD4SP that survived deletion and the percentage that became CD25+ cells 
(Figure 3.9C, middle and right panels, respectively). We observed a small, but significant 
increase in survival of EBI2 deficient OT-II CD4SP thymocytes at 10µM OVAp (Figure 
3.9C, middle panel). We also observed a consistent, though non-statistically significant, 
trend towards increased generation of CD4+ CD25+ Treg and Tregp from Ebi2-/- OT-II 
thymocytes (Figure 3.9C, right panel). This loss of significance for the difference in 
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CD4+CD25+ cells when normalized to 0nM slices results from the high variability and 
very small numbers of Treg in OT-II thymocytes in the absence of OVAp, Taken 
together, these data support the conclusion that EBI2 is required for efficient negative 
selection to weak self-antigens, and promotes negative selection over Treg generation in 




Figure 3.9 EBI2 promotes negative selection of OT-II CD4SP thymocytes responding to 
an endogenous self-antigen and restrains Tregp generation in thymic slices 
in the presence of OVAp. 
(A) Schematic of slice deletion experiments to assess negative selection and CD25 
upregulation by Ebi2+/+ and Ebi2-/- OT-II thymocytes in the presence or absence of 
OVAp. The gating schematic used to analyze slice deletion experiments is depicted. (B) 
The relative number of OT-II cells of the indicated subsets and genotypes in slices 
incubated with increasing concentrations of OVAp. Cell numbers were normalized for 
slice entry using the CD45.1 control, and then to the number of the corresponding subset 
input onto the slices (left and right panels) or to the number of the same subset present in 
slices without OVAp (middle panel). Data are representative of 3 independent 
experiments, using triplicate slices per condition. (C) Quantification of the percent of OT-
II CD4SP that responded to the indicated concentrations of OVAp by undergoing either 
deletion or upregulation of CD25 (left panel), that survived (middle), or that upregulated 
CD25 (right). Percentages were calculated relative to the number of CD4SP cells in slices 
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3.4.6 EBI2 expressed by thymic DCs is dispensable for intrathymic DC localization 
and negative selection of CD4SP cells 
We found that EBI2 is also expressed by thymic DCs (Figure 3.10A-B). Thus, the 
increased cellularity of Ebi2-/- OT-II CD4SP cells in RIP-mOVA- recipients (Figure 3.6) 
could EBI2 deficiency in the thymocyte and/or DC compartments. While slice deletion 
experiments using Ebi2-/- versus Ebi2+/+ OT-II CD4SP thymocytes undergoing negative 
selection on wild-type thymic slices (Figure 3.9) clearly revealed a T cell-intrinsic role 
for EBI2 in negative selection and Treg generation, we also evaluated the contribution of 
EBI2 in thymic DCs. EBI2 is known to regulate localization and survival of DCs in 
splenic bridging channels (145, 154), and could affect thymic DCs in a similar manner. 
While EBI2 was expressed by all three thymic DC subsets, Sirp⍺+DC, Sirp⍺-DC, and 
plasmacytoid DC (Figure 3.10B), Sirp⍺+ DC expressed the highest levels and were the 
only subset to undergo EBI2-dependent chemotaxis (Figure 3.10C). Because Sirp⍺+DCs 
migrate into the thymus from the periphery, EBI2 could promote their thymic 
recruitment. To test this, we evaluated cellularity of DC subsets in Ebi2-/- thymi. We did 
not observe significant differences in the total cellularity or subset distribution of thymic 






Figure 3.10 EBI2 deficiency in thymic DCs does not impair DC cellularity. 
(A) Relative Ebi2 mRNA levels in the indicated thymic stromal cell subsets from our 
previously reported gene expression profiling data (137). (B) Quantification of the MFI 
of GFP expression in thymic DC subsets from EBI2-EGFP knock-in mice of the 
indicated genotypes. (Ebi2+/+ n=4, Ebi2+/- n=6, Ebi2-/- n=9) (C) Quantification of the 
chemotactic index of Ebi2+/+ and Ebi2-/- DCs migrating towards the indicated 
concentrations of 7⍺,25-OHC in transwell chemotaxis assays. Data are representative of 
3 independent experiments. (D) The number of thymic DCs of the indicated subsets in 


































































































































































Furthermore, immunofluorescent analyses revealed that Ebi2-/- DCs are properly 
localized within the medulla (Figure 3.11). Thus, we were unable to detect a significant 
role for EBI2 in promoting thymic recruitment or medullary localization of DCs. 
 
Figure 3.11 EBI2 deficiency in thymic DCs does not impair intrathymic localization. 
(A) Representative Ebi2+/+ and Ebi2-/- thymic cryosections immunostained for Keratin5 
(green), to highlight medullary regions, and CD11c (red) to identify DCs. Scale 













To directly assess whether EBI2 deficiency in DCs could impact negative 
selection, we analyzed deletion of Ebi2+/+ OT-II CD4SP cells in Ebi2+/+ or Ebi2-/- thymic 
slices in the presence of increasing concentrations of OVAp (Figure 3.12A). Previous 
studies demonstrated that exogenously administered antigens are most efficiently 
presented by thymic DCs, relative to other thymic stromal subsets (155). Thus, if EBI2 
expression on DCs were required for efficient negative selection, we would expect that 
OT-II CD4SP cells would not undergo efficient negative selection on Ebi2-/- slices in 
response to OVAp. However, negative selection of OT-II CD4SP cells occurred 
equivalently on Ebi2+/+ and Ebi2-/- thymic slices, and CD25 was upregulated comparably 
(Figure 3.12A, B). Thus, we find no evidence that EBI2 deficiency in the thymic DC 
compartment contributes to impaired negative selection of OT-II CD4SP cells to weak 
endogenous antigens or to CD4+CD25+ generation in response to OVA. These findings 
further indicate that EBI2 expression in the thymocyte compartment is important for 






Figure 3.12 EBI2 deficiency in thymic DCs does not impair DC capacity to induce 
negative selection. 
(A) Schematic of slice deletion experiments to assess negative selection and CD25 
upregulation by Ebi2+/+ OT-II thymocytes on Ebi2+/+ versus Ebi2-/- thymic slices. The 
gating schematic used for analysis is also depicted (B) The relative number of 
CD4+CD25- and CD4+CD25+ cells in slices incubated with the indicated concentrations 
of OVAp were calculated by normalization to input cell numbers, as in Figure 5B. All 





























































































3.4.7 EBI2 is required for rapid motility and efficient medullary accumulation of 
CD4SP thymocytes 
EBI2 deficiency could impact negative selection by altering the capacity of CD4SP 
thymocytes to efficiently accumulate in the medulla and rapidly scan medullary APCs. To 
investigate this possibility, we used two-photon microscopy to image migration and 
localization of Ebi2+/+ and Ebi2-/- CD4SP cells in the cortex and medulla of pCX-EGFP 
live thymic slices (10) (Figure 3.13A). CD4SP thymocytes accumulate at a 5-10 fold higher 
density in the thymic medulla relative to the cortex (74). EBI2 deficiency resulted in a 
subtle but significant reduction in the enrichment of CD4SP cells in the medulla (Figure 
3.13B). Notably, Ebi2-/- CD4SP cells migrated at a significantly slower speed than Ebi2+/+ 
CD4SP cells, although the straightness of their trajectories was not altered (Figure 3.13C, 
3,13D). These results demonstrate that EBI2 deficiency impairs the capacity of CD4SP 
cells to migrate rapidly and to accumulate in the medulla, indicating that EBI2 contributes 





Figure 3.13 EBI2 contributes to accumulation within the medulla and promotes rapid 
motility of CD4SP cells. 
(A) A maximum intensity projection of Ebi2+/+ (blue) and Ebi2-/- (red) CD4SP 
thymocytes in live pCX-EGFP (green) thymic slices. The boundary between the cortex 
and medulla is indicated with a dashed line. Supplemental Video 1 shows the 
corresponding two-photon imaging data. Scale Bar= 50μm.  (B) The density (cells/µm2) 
of CD4SP cells in medullary versus cortical regions was quantified from images as in 
(A), and enrichment of CD4SP cells in the medulla was quantified as the ratio of 
medullary/cortical cell densities.  Lines connect the paired analysis of Ebi2+/+ and Ebi2-
/- CD4SP medullary enrichment on a single slice. Data are compiled from 3 independent 
experiments, with 5-9 slices analyzed per experiment. (Paired T-test) (C) Velocity and 
(D) straightness of Ebi2+/+ and Ebi2-/- CD4SP cells migrating on pCX-EGFP thymic 
slices were quantified after tracking cells from imaging data as in (A). Each dot 
represents the average velocity (C) or straightness (D) of 150-450 CD4SP cells imaged 












































































To ensure complete central tolerance, positively selected thymocytes must efficiently 
enter the medulla and migrate rapidly to encounter numerous, but sparse self-
peptide:MHC complexes displayed by mTECs and DCs. Here, we have identified a role 
for EBI2 in promoting central tolerance. We demonstrate that EBI2 deficiency results in 
impaired negative selection in response to a weakly negatively selecting ligand, and 
modulates the outcome of encounter with high affinity self-antigens in favor of Treg 
generation over negative selection. Although thymocyte cellularity and subset 
distribution are normal in Ebi2-/- mice, the TCR repertoire is altered, consistent with a 
role for EBI2 in thymocyte selection. Two-photon imaging revealed a mechanism by 
which EBI2 could affect negative selection: EBI2 promotes rapid motility and medullary 
accumulation of CD4SP cells, likely increasing the number of APCs encountered during 
medullary residence.	
In order to promote medullary accumulation, the EBI2 ligand 7⍺,25-OHC should be 
produced in the medulla. The synthesis of 7⍺,25-OHC requires the enzymes CH25H and 
CYP7B1 (139, 141). We find that CH25H is expressed preferentially by mTEClo cells, 
and our expression profiling data indicate that CYP7B1 is also expressed by TECs (not 
shown)(137). Furthermore, a previous study detected functional EBI2 ligands in the 
mouse thymus (156). Taken together, these findings indicate that a gradient of 7⍺,25-
OHC likely emanates from the thymic medulla. Consistent with this possibility, our two-
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photon imaging data reveal that EBI2 deficiency impairs the accumulation of CD4SP 
cells within the thymic medulla.  
Upon entering the medulla, thymocytes promote maturation of mTEC cells via 
signaling through TNFR superfamily members, such as RANKL and CD40L (39, 40, 42, 
100). Thus, the medullary compartment is small and disorganized in Ccr7-/- mice, likely 
due to the impaired capacity of CD4SP cells to interact with mTECs (73, 74, 134). We 
examined whether medullary accumulation of Ebi2-/- CD4SP could also impair mTEC 
differentiation. We did not find any defects in cortical/medullary organization in Ebi2-/- 
thymi, nor in upregulation of Aire in mTECs (data not shown). Thus, although EBI2 
contributes to medullary accumulation of CD4SP cells, it is dispensable for mTEC 
maturation, likely due to partial redundancies with other chemokine receptors. The 
increase in expression of EBI2 with CD4SP maturation suggests EBI2 would not affect 
entry of early post-positive selection CD4SP cells. These cells should undergo normal 
medullary accumulation due to signals from the chemokine receptor CCR4 (10), and 
could thus promote normal mTEC maturation. 
The chemokine receptors XCR1 and CCR2 have been implicated in DC localization 
in the thymus (71, 72). Because EBI2 was expressed by thymic DCs and induced their 
chemotaxis, we suspected EBI2 could promote thymic DC recruitment or medullary 
localization. However, Ebi2-/- DCs localized properly to the medulla, and were present at 
normal frequencies and numbers. In addition, EBI2-deficient DCs induced normal 
negative selection and Treg generation when presenting high-affinity negatively selecting 
peptides. Nonetheless, more subtle effects of EBI2 on thymic DCs could impact negative 
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selection. For example, mTECs transfer self-antigens to DCs for presentation to 
thymocytes (67). If EBI2 promotes proximity between DCs and mTECs, EBI2 deficiency 
could impair acquisition of antigens from mTECs, and thus alter the repertoire of 
peptides presented by thymic DCs  
Our results indicate that EBI2 cooperates with CCR4 and CCR7 to promote CD4SP 
medullary accumulation and central tolerance (10, 73-75, 134).  CCR4 is expressed by 
early post-positive selection DP and CD4SP thymocytes, while CCR7 is expressed by 
more mature CD4+ CD69+and CD4+ CD69- cells. Our expression and chemotaxis data 
suggest that EBI2 has the biggest impact on the more mature CCR7+ CD4SP cells.  Like 
CCR7, EBI2 also promotes rapid motility of CD4SP thymocytes, while CCR4 does not 
(10, 74). Interestingly, EBI2 deficiency resulted in, a 10% reduction in CD4SP speed. 
Given that CD4SP cells have a limited medullary residence time on the order of ~5 days 
(79), this reduction in velocity would diminish the chance that a cell will encounter any 
given medullary antigen. Because CCR7 and EBI2 have overlapping roles in CD4SP 
motility and localization, it would be interesting to determine if double deficiency for 
CCR7 and EBI2 more severely impacts thymocyte differentiation.  
Chemokine receptors can contribute to TCR activation, but our data do not 
support this activity for EBI2. Ebi2-/- OT-II thymocytes undergo normal negative 
selection in the context of the RIP-mOVA transgene. Furthermore a previous study 
showed that Ebi2-/- T cells upregulate activation markers (CD69) comparably after TCR 
stimulation (146). These findings support our conclusion that EBI2 impacts negative 
selection and Treg generation by promoting rapid motility and medullary accumulation of 
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CD4SP cells. However, it is not entirely clear why Ebi2-/- CD4SP cells are preferentially 
diverted to a CD4+CD25+ Treg fate, even in the presence of high-affinity self-antigens 
(both in vivo and in thymic slices). CCR7 and CCR4 can directly promote interactions 
between CD4+ T cells or thymocytes and APCs (10, 157).  EBI2 could promote 
interactions with APCs that induce strong TCR signals favoring negative selection over 
Treg generation. Alternatively, the slower speed of Ebi2-/- CD4SP cells could reduce 
serial engagement with APCs that would elevate TCR signaling beyond the threshold 
needed to induce negative selection, as opposed to Treg generation. Another possibility is 
that the slower velocity could result in accumulation of more soluble signals, such as 
common gamma cytokines like IL-2, within the local microenvironment of an APC that 
promote Treg generation. 
Previous study showed that EBI2 is required to guides activated CD4+ T cells 
towards follicles and the interaction with DCs in the outer T cell zone promotes 
differentiation of Tfh cells (146). This result could be related to our finding of decreased 
speed in Ebi2-/- thymocytes. It is possible that mislocalization of Ebi2-/- CD4+ T cells in 
secondary lymphoid organ is caused by the reduction of migration speed. Also, the fact 
that EBI2 deficiency causes CD4+ T cells mislocalization in secondary lymphoid organs 
correlates with our finding of less accumulation of Ebi2-/- CD4+ SP in medulla region in 
the thymus. Also, this slow migration speed may retain cells in a distinct area which 
could reduce efficient interaction with other cells. 
Single nucleotide polymorphisms near the Ebi2 locus have been associated with 
autoimmune disorders, including Type-1 diabetes, a T cell mediated disease (147). Thus, 
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although we have not observed overt autoimmunity in Ebi2-/- mice, EBI2 deficiency 
could contribute to central tolerance defects with autoimmune consequences in some 
cases. Interestingly we observed gene dosage effects of Ebi2 in chemotaxis assays. It is 
possible that the downstream signaling that are induced by EBI2 is dependent on gene 
dosage and requires certain amount of signal intensity. This is reminiscent of the gene 
dosage effect of CCR4 on autoantibody production (10). Thus, it is possible that 
individuals who are haploinsufficient for chemokine receptors impacting thymocyte 
medullary entry could be more susceptible to autoimmunity. The effect of EBI2 
deficiency on negative selection of OT-II cells in response to a weakly deleting 
endogenous antigen in C57BL/6J mice was significant, resulting in an almost 1.7-fold 
increase in CD4SP cells. Importantly, recent studies suggest that self-antigens near the 
threshold of negative selection for a given TCR are the most likely to result in export of T 
cells that can induce autoimmunity (158). Thus, subtle defects in negative selection 
driven by impaired chemokine receptor expression could contribute to autoimmunity. 
Because EBI2 plays multiple roles in distinct lymphoid subsets during an immune 
response, resolving the contribution of its impact on central tolerance versus peripheral 
lymphocyte responses is important. It will be informative to determine whether EBI2 is 
essential for negative selection of T cells that can otherwise induce autoimmunity. 
Altogether, our studies demonstrate that EBI2 contributes to the generation of central 




Chapter 4:  The role of GPR146 in thymocyte development5  
 
4.1 INTRODUCTION 
Thymocytes are hematopoietic progenitor cells that develop into T cells, which are 
vital to defense against foreign antigens. Thymocyte progenitors migrate from bone 
marrow to the thymus where they develop and are specifically programmed to become 
mature T cells (6). In order to establish the self-tolerance of maturing T cells, the thymus 
has a specialized microenvironment in the medulla. Thymocytes normally interact with 
antigen presenting cells in the medulla to avert auto-reactive thymocytes, but if T cells do 
not enter the medulla, autoimmune disease will arise. Therefore, it is important to elucidate 
which molecules induce thymocyte medullary entry, thereby preventing autoimmune 
disorders.   
Previous studies have shown that GPCRs, and particularly chemokine receptors are 
important for guiding positively selected thymocytes into the medulla, where they 
encounter the antigen presenting cells that induce central tolerance (159). For example, it 
is well documented that the chemokine receptor CCR7, which is highly expressed in single 
positive thymocytes, is critical for the accumulation of SP cells within the medulla and 
their negative selection. The CCR7 ligands CCL19 and CCL21 are highly expressed by 
                                                
5 Authorship contributions: Sanghee Ki performed most of experiments, with advice from Lauren Ehrlich. 
Sanghee Ki performed southern blot, with help from Qiang Li and advice from Steven Vokes. Zicheng Hu 
generated qRT-PCR data of GPR146. UT mouse core facility generated chimera mice. 
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mTECs, resulting in a chemokine gradient, attracting SP cells towards the medulla (159). 
CCR7-deficient CD4SP have decreased medullary enrichment and deficient negative 
selection, resulting in autoimmune disease in Ccr7-/- mice. However, Pertussis Toxin 
(PTX), which inhibits GPCR signals, completely abolishes medullary entry of SP 
thymocytes, while CCR7 only reduces the accumulation of SP cells in the medulla, 
suggesting that other GPCRs are involved in governing medullary entry and negative 
selection (74).  
GPR146 is a member of the Rhodopsin family of GPCRs. It was identified by using 
the Hidden Markov Model to search the human genomic data set to find new GPCRs (160). 
Human GPR146 blast results showed that GPR146 has a 23% homology in amino acid 
sequence with CCR7, which is essential for thymocyte migration and development. 
Interestingly, GPR146 shows an expression pattern similar to that of CCR7, based on our 
microarray expression profiling data (137). GPR146 was regarded as an orphan receptor 
until 2013 when Yosten et al demonstrated that c-peptide, an intermediate product in the 
transition from proinsulin to insulin, was a ligand for GPR146 (161). They showed that 
GPR146 co-localized with c-peptide on the membrane of KATOIII cells and was essential 
for c-Fos expression in response to c-peptide-induced signaling. A previous study showed 
that human CD4SP cells migrated toward c-peptide in vitro, further suggesting that 
GPR146 could promote chemotaxis of thymocytes (162). However, the role of GPR146 in 
thymocyte development remains largely unknown.  
In this study, we generated Gpr146-/- mice using a GPR146 targeting vector from 
the KOMP repository to explore the role of GPR146 in the thymocyte differentiation and 
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selection. Initial studies indicate that Gpr146-/- mice do not have altered thymocyte 
cellularity or subset composition, and the organization of cortical and medullary regions 
are intact. However, in competitive bone marrow chimeras Gpr146-/- CD4SP and CD8SP 
out-competed wild type cells, suggesting GPR146 may impact the survival, proliferation 
or selection of post positive-selection thymocytes. In this chapter, I describe the generation 
and initial characterization of Gpr146-/- mice. 
 
4.2 EXPERIMENTAL PROCEDURES 
Mice 
C57BL/6J (CD45.2), B6.SJL-Ptprca Pepcb (CD45.1) mice were purchased from 
The Jackson Laboratory. CD45.1/CD45.2 were bred in-house. GPR146 chimeric mice 
were generated by electroporation of V6.5, 129;C57BL hybrid ES cells with a GPR146-
targeting allele. The ES cells used for injection were. Five generation of backcrossing 
resulted in a 98.375% C57BL/6j background.  
 
Vector preparation and ES cell transfections 
A GPR146 targeting vector (GPR146-tm1aKOMP Mbp) was purchased from the 
KOMP repository. The vector was in DH10 E.coli and amplified by culturing in Lysogeny 
broth (LB) media. Maxiprep (Qiagen) was performed following the manufacturers 
protocol. 50ug of targeting vector was linearized by digesting with AsisI enzyme (NEB).  
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The digest was confirmed by gel analysis. Linearized vector was inserted into ES cells by 
electroporation which is performed by the UT mice core facility. 
 
Southern blot for screening 
After electroporation, we obtained duplicate plates from the mice core facility. 
Approximately 300 ES cells transfected with the targeting vector in a 96-well plate were 
lysed with lysis buffer [10nM Tris-HCL pH8.0, 10nM EDTA pH8.0, 10nM NaCl, 1mg/ml 
proteinase K (freshly added)]. The plate was incubated overnight at 65°C followed by an 
incubation with DNA precipitation solution [100% EtOH, 75mM NaCl] for 30min at room 
tempterature (RT). The precipitate was recovered by careful removal of the supernatant 
and air-drying. The dried precipitate was digested with 10-15U of DraI (5’ probe and Neo 
probe) and AvrII (3’ probe) enzyme at 37°C overnight in what volume of 25µl. Digested 
DNA was loaded on gels followed by transfer to a membrane (Biodyne or Hybond N+) 
overnight. DNA on the membrane was detected using 32P labeled probes. Primers that 
were used for making the probes are listed are below: 
5’probe forward primer:  5’- GGACAGCGTCCACTGCTTAC-3’ 
5’probe reverse primer:  5’- TCGGGCAAGAACAGAACGACAC-3’ 
3’probe forward primer: 5’-GTTAGAAGACTTCCTCTGCCCTCAGTTGGCTAGGG-
ACAGGACC-3’ 
3’probe reverse primer:  5’- AAGCAGGGAGTGGTGGTCAG-3’ 
 
Generation of BM chimeras 
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Gpr146+/+ (CD45.1) andGpr146-/- (CD45.2) bone marrow cells were obtained from 
two long bones. Thymocytes were incubated with CD3, CD4, CD8, Mac1, Gr1, Ter-119, 
NK1.1, and B220 antibodies for 30min at 4°C to deplete mature hematopoietic lineages. 
After washing with FACS wash buffer (FW; PBS+ 2% bovine calf serum [BCS]; 
GemCell), anti-Rat IgG Magnetic Beads (Invitrogen) were incubated with the cells (beads 
and cell ratio = 1:4) for 10 minutes at RT and then washed 2 times in FW. Cells were then 
magnetically depleted, and the flow-through lineage depleted cells were collected.  
Gpr146+/+ and Gpr146-/- BM donor cells were mixed at 1:1 ratio and injected intraorbitally 
into recipient CD 45.1/45.2 congenic mice. Six weeks after injection, thymi were analyzed 
by LSR Fortessa flow cytometer (BD) 
 
qRT-PCR  
Thymi from Gpr146+/+ or Gpr146-/- mice were stained with antibodies against CD8, 
CD69, Lin (B220, Gr-1, Ter119, NK1.1, Mac1, CD11c, γδTCR), CD3, and CD4 to 
distinguish thymocyte subsets. Immunostained cells were sorted on a FACSAria II (BD) 
and 5x104 ~ 1x105 cells were subjected directly to Trizol to extract RNA. cDNA was 
synthesized using SuperScript® III First-Strand Synthesis SuperMix (Life Technologies). 
qRT-PCR using SyBr (Applied Biosystems) was carried out with the following primers:  
-GPR146 forward primer for qRT PCR :  5’-GGGGTCCCTGTGAGCTTAG-3’ 




All antibodies were obtained from eBioscience or Biolegend unless otherwise 
indicated: anti-CD8 (53-6.7), -CD69 (H1.2F3), -CD3 (145-2C11), -CD4(RM4-5), -CD25 
(PC61.5), -CD45.1 (A20), -CD45.2 (104), -CD11c (N418), -Ter119 (TER-119), -B220 
(RA3-6B2), -Gr-1 (RB6-8C5), -CD11c (M1/70), -NK1.1 (PK136), -cKit (2B8), -CD31 
(390), -Sirp⍺	(P84), -I-A/I-E (M5/114.15.2), -CD80 (16-10A1), -CD45 (30-F11;BD), -
Ly51 (6C3), -EpCAM (G8.8). Anti-Streptavidin Qdot®-605 (Life Technologies) was 
used as a secondary reagent to detect biotinylated primary antibodies. 
Antibodies used for immunofluorescent stains are listed below: anti-Pancytokeratin-
FITC (C-11; Sigma-Aldrich), -keratin5 (rabbit polyclonal antibody; Covance), Donkey 
anti-rabbit IgG DyLight 594 (Jackson ImmunoResearch Laboratory). 
 
Immunofluorescence staining 
Thymi from one month old Gpr146+/+ and Gpr146-/- mice were harvested and snap 
frozen in OCT (manufacturer). 6-9 µm sections were obtained using a Microm HM550 
Cryostat (ThermoFisher) and stored at -80°C. Cryosections were fixed in 100% acetone at 
-20°C for 15min and washed 2X in PBS + 0.1% Tween 20. Immunostaining was carried 
out for 1hr at 4°C with indicated primary antibodies against the following: Keratin5 (rabbit 
polyclonal), PanCK (C11)-FITC. Images of stained sections were observed using an 




4.3.1 Generation and confirmation of GPR146 deficient mice  
By analyzing our expression profiling dataset (137), we identified Gpr146 as a  
GPCR protein that could be involved in medullary accumulation of post positive selected 
thymoctyes. Gpr146 transcripts are expressed in post-positive selection DP cells and levels 
are sustained in CD4SP and CD8SP. Given that GPR146 has been implicated in 
chemotaxis of human CD4SP (162), we hypothesized that GPR146 is involved in the 
migration of SP cells into the medulla, and would thus affect central tolerance. We 
performed qRT-PCR to confirm the expression pattern of Gpr146, and found that it is first 
expressed in positively selected DP cells and further upregulated in both CD4SP and 
CD8SP thymocytes. Additionally, we found that the DN1 population (c-Kit+, CD44+, 
CD25-) expresses detectable levels of GRP146 (Figure 4.1), indicating that it may also 
regulate early progenitors. 




Figure 4.1 Expression of Gpr146 transcripts in thymocyte subsets  
Gpr146 transcript levels were quantified by qRT-PCR on cDNA from FACS purified 
thymocyte subsets from C57BL/6J mice. Gpr146 is up-regulated in positively selected 
DP (DP CD69+) and expression remains in both CD4 and CD8 SP cells. Relative 
expression is calculated by normalizing to DN3b subsets. Representative of 2 
independent experiments. Means±SEM. 
 
 To test the role of GPR146 in T cell development and selection, we generated 
GPR146 deficient mice. A GRP146 “knock-out first” targeting vector was obtained from 
the UCDAVIS KOMP repository (Knockout mouse project). GPR146 has 2 exons, one in 
a non-coding and a second (Exon2) encoding GPR146. In the targeting vector, Exon 2 is 
flanked by loxP sites, and is preceded by a FRT-LacZ-neomycin-FRT fragment. Because 
of the polyadenylation signal after LacZ, mice homozygous for the “knockout first” allele 
express lacZ instead of GPR146, allowing us to generate a constitutive GPR146 knockout. 
(Figure 4.2) (163).  
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In order to generate thymus-specific GPR146-deficient mice, we can cross GPR146 
knockout mice with ROSA26Flpo mice. ROSA26Flpo mice express the Flpo gene in the 
broadly expressed ROSA26 locus and show efficient deletion of sequences flanked by FRT 
sites (164). This will eliminate lacZ and neo genes, leaving only exon2 flanked by loxP 
sites. This GPR146fl allele will enable us to delete exon2, which contains the entire coding 
sequence of GPR146, in a tissue specific manner. Then GPR146fl/fl mice can be bred with 
Lck-cre mice, which express the recombinase Cre under control of the T cell specific Lck 
promoter, inducing deletion at DN stage of T development (165). 
The vector was introduced into V6.5, 129:C57BL/6J hybrid ES cells by 
electroporation. ES cell colonies were screened by Southern blot for proper homologous 
recombination with the vector sequence, and a number of colonies containing a correctly 
targeted allele were identified.  These were confirmed by probing with 5’, 3’, and 




Figure 4.2 GRP146 targeting strategy  
In the targeting vector, Exon 2 is flanked by loxP sites and the inserted lacZ and Neo 
genes are flanked by FRT sites. Enzyme sites used for southern blots are indicated by red 
and blue arrows. Neo, 5’ and 3’arm probes for southern blots are indicated by the pink 
bars.  
 
Three of the ES cell colonies were injected into C57BL/6J blastocysts, and 
implanted in pseudo-pregnant females. Fifteen chimeras out of a possible 29 were obtained 
and five of these (one from E5, two each from E8 and D10) were bred with B6 female 
mice. The germ line transmission efficiency in male pups from chimera breeding was 
almost 100%. We are now maintaining two founders (E8 and D10), backcrossing them 
GPR146 WT allele GPR1465’ arm






5’ arm GPR146 3’ arm
Probe
Targeting Vector hBactP neo pAIRES lacZ pAEN2SA5’ arm GPR146 3’ arm
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onto a C57BL/6J background for five generations to obtain a 98.365% C57BL/6J congenic 
strain.  
By taking advantage of the GPR 146 “knockout first” allele, we could determine 
the protein level of LacZ in the GPR146 locus as an indication of which thymocyte subsets 
would express GPR146 protein. Figure 4.3B shows the MFI of lacZ in Gpr146+/+ and 
Gpr146+/- mice. Consistent with our qRT-PCR data, we observed that GPR146 is highly 
expressed in CD4SP and CD8SP. However, DP CD69+ expression was lower than 
expected, which can be explained by the time delay between RNA transcript and protein 
generation. In our final strain of backcrossed mice which is either from E8 or D10, we also 
confirmed that mRNA expression of Gpr146 was eliminated in thymocytes by qRT-PCR. 
Sorted thymocytes from Gpr146+/+ mice showed high expression of GPR146 in CD4 and 





Figure 4.3 Confirmation of GPR146-/- ES cells and resultant mice  
(A) Southern blot for screening GPR146 targeted ES cell lines. We confirmed proper 
insertion of the targeting vector using 5’, 3’, and neomycin probes. V6.5 are negative 
control ES cells, and E5, E6, E7, E8, and D10 were targeted ES cell lines, and E9 was a 
negative result. E8 and D10 which were used to generate GPR146-/- chimera mice are 
indicated by red rectangles. (B) Mean Fluorescence Intensity of lacZ in Gpr146+/+ and 
Gpr146+/- thymocyte subsets. (n=3) (C) qRT-PCR of sorted thymocyte subsets from 
Gpr146+/+ and Gpr146+/- mice. Data are representative of two independent experiments. 
  



























































































































4.3.2 Gpr146-/- mice do not show gross defects in thymocyte cellularity or subset 
composition  
To determine if deletion of GPR146 impacts thymocyte development, we compared 
the cellularity and composition of thymocyte subsets in Gpr146+/+ and Gpr146-/- mice by 
flow cytometry. The cellularity of thymus, spleen, and lymph nodes were comparable 
between Gpr146+/+ and Gpr146-/- mice (Figure 4.4). There was also no differential subset 
distribution between Gpr146+/+ and Gpr146-/- thymocytes.  
 
 
Figure 4.4 Comparison of cellularity and thymocyte composition between Gpr146+/+ and 
Gpr146-/- mice  
(A) Comparison of the cellularity of thymus, spleen, and lymph nodes from Gpr146+/+ 
and Gpr146-/- mice 4 to 6 weeks of age. Means±SEM (n=6) (B) Comparison of 




Previous studies indicated that the signal from positively selected thymocytes is 
essential for establishing proper medulla development (39) Additionally, CCR7 deficient 
mice accumulated fewer single positive thymocytes in medullary regions and developed 
small and disorganized medullas (166). Therefore, we investigated whether Gpr146-/- mice 
had disorganized medullary architecture. Initial analyses of immunofluorescence images 
of thymic cryosections immunostained to reveal cTEC (PanCytokeratin) and mTEC 
(Keratin5) markers suggest that Gpr146-/- thymi might have larger medullary regions than 
Gpr146+/+mice. However, a greater number of wild type images will be needed to 
determine if this apparent difference is significant (Figure 4.5A). Quantification of cortical 
and medullary regions by K-mean clustering did not reveal significant differences between 




Figure 4.5 Gpr146-/- thymus do not show a subtle defect in cortical/medullary 
organization. 
(A) Representative image of immunostained thymic cryosections from Gpr146+/+ and 
Gpr146-/- mice (one month old). PanCytokeratin (green) reveals cortical regions while K5 
(red) demarcates the medulla. Scale bar=1000µM (B) Quantification of medulla and 
cortex regions by K-mean clustering from images as in A. Means±SEM (Gpr146+/+ n=1, 




4.3.3 Competitive bone marrow chimeras reveal a role for GPR146 in thymocyte 
differentiation  
To determine whether the contribution of GPR146 to thymocyte development 
would be more pronounced in a competitive situation, we analyzed thymocyte 
development in mixed bone marrow (BM) chimeras, in which GPR146 deficient 
thymocytes competed with wild type cells in a wild-type thymic environment. BM cells 
were harvested from congenically marked Gpr146+/+ (CD45.1) and Gpr146-/- (CD45.2) 
mice, depleted of mature lineages, and mixed at 1:1 ratio. This donor mixture was injected 
into congenically marked (CD45.1/CD45.2), lethally irradiated recipient mice, and thymic 
chimerism was analyzed six weeks after transplantation. Interestingly, we found that the 
Gpr146-/- (CD45.2) thymocytes contributed preferentially to the CD4 and CD8 SP 
compartments, in which GPR146 is normally highly expressed (Figure 4.6A). These results 
suggest many possible roles of GPR146. Deficiency of GPR146 may cause less effective 
negative selection, which would increase the number of CD4SP and CD8SP thymocytes. 
Also, deficiency of GPR146 may induce increased proliferation, decreased apoptosis, and 
increased retention of CD8SP and CD4SP thymocytes in the thymus. The increase in the 




Figure 4.6 BM chimeras reveal an elevated contribution of Gpr146-/- in CD4SP and 
CD8SP  
(A) Graph showing ratio of CD45.2(Gpr146-/-) to CD45.1(Gpr146+/+) in chimeric 
thymus. Means±SEM (Gpr146+/+ n=8, GPR146-/- n=9). *, p-value <0.05, **, p-value 
<0.01 (B) Graph showing ratio of CD45.2(Gpr146-/-) to CD45.1(Gpr146+/+) in chimeric 
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4.4 DISCUSSION 
In this study, Gpr146-/- mice were generated to investigate the role of GPR146 in 
thymocyte development. Based on expression profiling data, we found that the expression 
pattern of GPR146 was similar to that of CCR7 in that they are both upregulated in 
maturing SP thymocytes. Together with previous studies indicating that GPR146 is a 
chemokine receptor and the homology between CCR7 and GPR146, this expression pattern 
suggests GPR146 could contribute to SP thymocyte medullary entry and negative 
selection. Although Gpr146-/- mice showed no gross defects in thymocyte cellularity and 
subset composition, Gpr146-/- thymocytes contributed preferentially to CD4SP and CD8SP 
compartments when competing against wild-type thymocytes. These findings indicate that 
GPR146 impacts SP thymocyte differentiation, potentially affecting negative selection and 
migration of SP cells.  
Deficiency of a chemokine receptor in thymocytes could affect thymocyte 
development in many ways. First, it has been shown that the crosstalk between thymic 
epithelial cells and developing thymocytes is critical for maturation and maintenance of 
both compartments. Therefore, disrupting GPR146 may interfere with development of the 
thymic stroma. For example, mice deficient for Ccr7 have altered thymic architecture, with 
small medullary regions dispersed throughout thymus and extending to the subcapsule 
(167). This could be due to a decreased ability of Ccr7-/- T cells to localize to the medulla 
and provide the RANKL signals responsible for regulating proliferation and maturation of 
mTECs (136). Secondly, GPCR deficiency could impair thymocyte development in a cell-
intrinsic manner by altering TCR signaling (136, 168), migration (74, 134), localization 
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(167), and interaction with APCs (10). Thus, GPCRs, and chemokine receptors in 
particular, can contribute to maintenance of proper thymic structure as well as thymocyte 
development. Based on our analysis of Gpr146-/- thymocytes, we conclude that deficiency 
of GPR146 does not induce changes in total thymocyte cellularity and subset composition. 
However, it appears that deficiency of GPR146 increases thymocyte compartments in our 
BM chimera experiment. (Figure 4.6) Future studies will further elucidate how GPR146 
affects thymocyte development. 
Given that GPR146 is highly expressed in positively-selected SP cells which 
accumulate in the medulla and are subject to negative selection, GPR146 may contribute 
to these processes. SP cells in the thymus move faster and with straighter trajectories than 
DN or DP cells. Moreover, movement of SP cells in the medulla is slightly faster than 
migration in the cortex, consistent with their need to scan rare TRAs presented on mTECs 
in the medulla (74). CCR7 deficiency abrogates chemotaxis of CD4 SP cells towards the 
medulla and reduces their velocity relative to WT cells. However, CCR7 deficiency does 
not prevent medullary entry of SP cells, though Ccr7-/- CD4 SP cells accumulate less 
efficiently in the medulla. This indicates that CCR7 contributes to CD4 SP chemokinesis, 
chemotaxis towards the medulla, and accumulation within the medulla, but CCR7 is not 
required for medullary entry (74). Furthermore, a previous study showed that Ccr7-/- 
thymocytes had an impaired cell-intrinsic response for TCR-mediated signaling required 
for negative selection (136). Thus, it is possible that other GPCRs such as GPR146 could 
also directly contribute to TCR-mediated signaling, migration, medullary entry, and 
negative selection processes.   
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C-peptide is an intermediate product generated during the cleavage of pro-insulin 
to form the mature form of insulin (169). C-peptide is present in the blood stream of type2 
diabetes patients. Previous studies have shown that C-peptide has the chemotactic capacity 
to recruit human CD4SP in vitro, which in turn is involved in pertussis toxin sensitive G 
protein signaling. Additionally, in Type 2 diabetic patients, it has been shown that c-peptide 
and CD4+ T cells colocalize in early arteriosclerotic lesions (162). However, a receptor that 
is involved in c-peptide signaling was not identified until Yosten et al showed that c-
peptide is the ligand for GPR146 (161). mTEChi expresses insulin as TSA. Therefore, it is 
possible that c-peptide generated by insulin expressing mTEC cells could induce 
chemotaxis of CD4SP and CD8SP towards the thymic medulla. Future studies using two-
photon microscopy to analyze migration of Gpr146-/- thymocytes will address this 
possibility. 
It has been shown that if insulin is deficient in a thymic specific manner, mice 
develop autoimmune diabetes (170), and the working model is that this is due solely to 
impaired negative selection against insulin itself. This paper reveals that thymic specific 
deletion of insulin is sufficient to induce insulin specific autoimmune disease. There is also 
a possibility that chemotaxis of CD4SP induced by c-peptide is impaired in this model. 
Determining whether Gpr146-/- mice are subject to autoimmune disease will be critical in 





Chapter 5: Summary and Future Directions 
 
In this dissertation, I addressed three different aspects of thymocyte development. 
In Chapter 2, I identified molecular signatures in TECs and DCs in early thymic involution. 
In Chapter 3, I identified a role for EBI2 in promoting rapid motility of SP cells and 
efficient negative selection. In Chapter 4, I described the generation and initial 
characterization of thymocyte development in Gpr146-/- mice.  
 
Understanding the gene expression changes of thymic stromal cells during aging  
 
 In Chapter 2, we analyzed global transcription profiles of purified thymic stromal 
cells to reveal the molecular players contributing to thymic atrophy associated with aging. 
By analyzing changes in gene expression levels, we found a prominent decrease in E2F3 
target gene levels and expression of cell-cycle related genes in mTEClo and cTEC 
populations. E2F3 is a master transcription factor that controls cell cycle progression. 
Interestingly, E2F3 mRNA levels were unchanged, suggesting that other factors involved 
in regulating E2F3 activity were involved. Previous studies demonstrated that RB family 
mutant TECs showed an E2F3 mediated increase of Foxn1 expression, which prevents 
thymic involution (94). Therefore, further studies of molecular mechanisms underlying Rb 
family genes and E2F3 are needed. 
While our studies suggest a key role for diminished E2F3 activity in thymic 
atrophy, the mechanism by which these transcriptional targets impact TEC function is 
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currently not known. A decrease in E2F3 target genes may directly lead to thymic atrophy 
through reduction of the turn-over rate of all TEC subsets. Alternatively, a rare TEC subset 
with stem cell or transit amplifying properties could be particularly affected by the loss of 
E2F3 Interestingly, a recent study showed that bipotent adult thymic epithelial cells that 
retain stem/progenitor activities reside within mTEClo integrin-α6hi Sca-1hi subsets (171).  
Further studies are needed to reveal molecular and cellular mechanisms by which E2F3 
activity impacts TEC cellularity during age associated thymic involution.  
Moreover, we found that DC and DCS showed pro-inflammatory signals in aged 
mice, which also may contribute to thymic involution. We found that Il1a and Il1b were 
upregulated in DC and DCS at 6months. Interestingly, Il-1 activating receptors are present 
on cTEC and fibroblasts. Additional studies on Nlrp3-deficient mice, which are deficient 
for active IL-1, showed that cTEC compartments were preferentially sustained compared 
to other stromal subsets (131). Given that the administration of IL-1 induces thymic 
atrophy (97), this suggests that IL-1 plays a role in contributing to thymic involution.     
 Given that expression of the E2F3 transcription factor does not change with age, it 
will be intriguing to see if there are any other modulators that control E2F3 activity in 
mTEClo and cTEC. Also, it has been shown that E2F3 controls Foxn1, which is important 
for thymic epithelial cell development. Rb mutant mice have high activity of E2F3 and 
high expression of Foxn1, which results in sustained thymic growth and the prevention of 
involution with age (94). Another study showed that FOXN1 can also promote expression 
of cell cycle genes such as Ccnd1(88). Therefore, it will be important to investigate whether 
an increase in cell cycle activity alone downstream of E2F3 and FOXN1 activity prevents 
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the age-associated decline in TEC function, or whether other cell cycle pathways, along 
with E2F3 and FOXN1, prevent involution. These studies would reveal candidate pathways 
that could be targeted to restore or retain thymic function, and thus a diverse and self-
tolerant T cell repertoire to promote functional immunity throughout the lifespan.  
  
Elucidating the role of chemokine receptors in thymocyte interactions with stromal 
cells  
 
In Chapter 3, we investigated the role of EBI2 in thymocyte development and 
selection. EBI2 has been shown to promote chemotaxis of multiple lymphocyte subsets, 
including B cells, DCs, and naïve T cells, and the endogenous EBI2 ligand, 7α25-OHC, 
has been identified (139, 141). We found that Ebi2 is upregulated in post-positive 
thymocytes, and the enzyme CH25H, which is required to generate 7α25-OHC is 
expressed by mTEClo cells. This suggests that EBI2 could promote migration of SP 
thymocytes toward medulla; however, further two-photon microscopy studies in which 
chemotaxis of SP cells is evaluated will be required to fully address this possibility. 
Consistent with a possible role for EBI2 in promoting chemotaxis of SP cells towards the 
medulla, we did identify a slight defect in medullary accumulation in EBI2-deficient SP 
cells. Strikingly, Ebi2-/- CD4SP migrated more slowly than wildtype thymocytes. In 
keeping with the idea that rapid SP motility would be important to scan APCs presenting 
self-peptides to induce negative selection, we found that Ebi2-/- OTII cell were impaired in 
their ability to undergo negative selection to an endogenous C57BL/6J self-antigen. Also, 
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Ebi2-/- OT-II cells preferentially diverted towards a regulatory T cell fate in the presence 
of the high-affinity OVA antigen. These studies demonstrate a previously unanticipated 
role for EBI2 in promoting thymocyte negative selection.  
 Our studies revealed that EBI2 did not affect negative selection in response to an 
abundant exogenous antigen or an endogenous high affinity antigen, but rather affected 
negative selection in response to weakly deleting endogenous antigens. We speculate that 
thymocytes have a greater chance of encountering sufficient self-peptide:MHC complexes 
to trigger negative selection if there are abundant self-antigens, as would be the case when 
OVAp was added to thymic slices, leading to imperceptible differences in negative 
selection in the absence of EBI2 in this system. However, in the case of rare or much lower 
affinity endogenous self-antigens, the 10% reduction in the migration speed of SP 
thymocytes caused by EBI2 deficiency could significantly reduce the likelihood of 
encountering enough self-peptide:MHC complexes to push the thymocyte over the 
threshold of TCR signaling required for negative selection. Furthermore, our data showed 
that in the presence of abundant high affinity antigens, cell fate decision to undergo 
negative selection versus Treg generation is modified by EBI2. Previous studies showed 
that CCR4, another chemokine receptor, promoted interactions between DCs and CCR4-
expressing thymocytes (10). We speculate that EBI2 could directly contribute to 
interactions between CD4SP cells and mTEClo cells, which might contribute to mTEC 
differentiation, thus impacting thymocyte development. However, our current studies did 
not reveal a defect in mTEC differentiation. It is also possible that interactions between SP 
thymocytes and mTEClo cells have an unanticipated role in promoting negative selection. 
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It will be interesting to see if EBI2 has a direct effect on the interaction between thymocytes 
and mTECs.  
 Also, because EBI2 is not the only receptor contributing toward accumulation of 
CD4SP in the medulla, it will be important to distinguish the contribution of other 
chemokine receptors. For instance, CCR7 and CCR4 have prominent roles in thymocyte 
migration into the medulla and may mask effects of EBI2 deficiency. EBI2 has been shown 
to have large role in B cell and DC migration in secondary lymphoid organs (138, 142, 
154, 172). EBI2 is also related to autoimmune disease such as type I diabetes and Multiple 
sclerosis (MS) (147, 173). Although we could not find evidence showing apparent 
autoimmunity in Ebi2-/- mice, autoimmune disease can be induced by EBI2 in various 
ways. It will be important to study whether EBI2 promotes autoimmunity at least in part 
through its effects on central tolerance in the thymus.  
In Chapter 4, we identified GPR146 as a candidate GPCR that could contribute to 
thymocyte medullary entry and/or negative selection and generated GPR146 knockout 
first mice to evaluate the contribution of GPR146 to thymocyte development and 
selection. Not only is GPR146 up-regulated just after thymocytes enter the medulla, 
which is consistent with a role in medullary entry, but GPR146 also has homology with 
CCR7, a known chemokine receptor that drives medullary entry (174). Based on these 
findings, we hypothesized that GPR146 may contribute to thymocyte medullary entry and 
central tolerance. We generated GPR146 deficient mice and found that a higher 
proportion of CD4+CD69-, CD8+CD69+, and CD8+CD69- thymocytes were derived from 
Gpr146-/- progenitors in thymi of mixed bone marrow chimeras. This indicates that 
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GPR146 may play a role in negative selection of CD4SP and CD8SP thymocytes. 
However, further studies are required to determine if GPR146 is required for efficient 
negative selection and if GPR146 is required for TCR signaling, migration, or interacton 
with APC. In the future, we will generate additional bone marrow chimeras to address the 
role of GPR146 in negative selection. We will generate Gpr146-/- OT-I and OT-II TCR 
transgenic mice. Given that OT-I and OT-II transgenic mice have a monoclonal TCR on 
all thymocytes and T cells with specificity for peptides of Ovalbumin displayed on MHC-
I and MHCI-II molecules, respectively, we will examine the impact of GPR146 
deficiency on negative selection in chimeras where OVA is expressed as a model TRA in 
mTEChi cells. Because CCR7 can induce medulla accumulation and negative selection, 
and because it would be expressed normally on GPR146 deficient T cells, we may not 
observe defects in negative selection. In this case, we would breed Gpr146-/-; Ccr7-/-mice 
and examine the impact on the polyclonal repertoire. Furthermore, by breeding the mice 
doubly deficient for the chemokine receptors to OT-I or OT-II mice, we could determine 
if the double knockout is more severely impaired in its capacity to undergo negative 
selection than either single knockout mouse. 
C-peptide, which is generated during the conversion of pro-insulin to Insulin, is a 
candidate ligand for GPR146. It will be important to determine if GPR146+ thymocytes 
respond to c-peptide via chemotaxis or other cell signaling pathways. Insulin is expressed 
at low levels by mTEChi cells (52), which raises the question of whether c-peptide is 
abundant in the thymus and available to promote SP chemotaxis.  
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In the future, two-photon imaging experiments will test whether GPR146 is 
involved in medullary entry, the accumulation of SP cells, and other aspects of T cell 
motility that could impact the efficiency of negative selection. Furthermore, it will be 
important to evaluate the possibility that GPR146 activation could directly contribute to 
TCR-mediated signal transduction. Future studies are needed to elucidate the role of 
GPR146 in thymocyte development and selection and to uncover the mechanisms by which 
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